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Abstract 
More than a half of the world’s population are infected with one or more 
species of intestinal worms of which the nematodes Ascaris lumbricoides, 
Trichuris trichiura and the hookworms are the most common and important in 
terms of child health.  This paper: a) introduces the main species of intestinal 
worms with particular attention to intestinal nematodes; b) examines how such 
worms may affect child growth and nutrition; c) reviews the biological and 
epidemiological factors that influence the effects that worms can have on the 
growth and nutrition of children; c) considers the many factors that can affect 
the impact of treatment with anthelmintic drugs; d) presents the results of a 
meta-analysis of studies of the effect of treating worm infections on child 
growth and nutrition; e) discusses the results in terms of what is reasonable to 
expect that deworming alone can achieve; f) describes some important 
characteristics of an ideal study of the effects of deworming; and g) comments 
on the implications for programmes of recommendations concerning mass 
deworming. 
 
 
Keywords 
Intestinal worms, anthelmintics, children, growth, nutrition 
 
Key messages 
• The effects of intestinal worms depend on the species, the mixture of 
species, the duration of infection and on the number of worms. 
• The distribution of worms among hosts is highly skewed so that only a 
minority of infected individuals have moderate to heavy infections and 
are likely to be diseased. 
• The impact of infections will also depend on the size and nutritional 
status of the host. 
• Treating worms can lead to improvements in growth and nutritional 
status but deworming alone does not treat any underlying nutritional 
deficits that have been caused or made worse by worms, so extra 
energy, protein and micronutrients are required. 
1. Introduction 
Parasitic worms are among the most common and widespread infections of 
humans in the world today.  Using recent estimates of the prevalence of the 
four main species of intestinal nematode worm (de Silva et al., 2003) a simple 
calculation that assume the probability of infection with one worm is 
independent of infection with another, indicates that about 48% of the 5 billion 
or so people living in the developing world are infected with at least one 
species, while almost 10% are infected with at least two species.  But, if some 
2.3 billion people in the developing world are infected with intestinal nematode 
worms, why isn’t disease due to worms more common, and why don’t they 
seem to have a greater and more noticeable impact on the health of children?  
This review will attempt to explain why, it will review the studies that have 
been done to examine the impact of treating intestinal nematode worms on 
children’s nutritional status and growth, and it will examine the scientific and 
experimental problems with estimating the impact that worms in general have 
on human health. 
 
1.1 The gastro-intestinal ecosystem 
The human intestinal tract provides a protected habitat for several hundred 
species of viruses, bacteria, yeasts, protozoa and worms.  All the organisms 
that live in the intestinal ecosystem are parasites, because they are 
dependent for their existence on their host, and the basis of this dependence 
is usually nutritional (Hall, 1985).  The parasitic life-style is highly successful 
for worms in general mainly because, once established within a host, there 
are no predators and life is a sheltered steady state with a constant supply of 
nutrients that is sustained by the host’s homeostatic mechanisms.    
 Because the gut is a cavity within the host, it is said to be 
immunologically privileged, as the organisms living there are not exposed to 
the full force of the human immune system.  Nevertheless, intestinal worms do 
elicit an immune response, and hookworms and whipworms in particular come 
into contact with both the cellular and humoral immune systems to elicit a Th-
2 responses and cause a rise in the concentration of IgE (Else, 2005).  But the 
fact that intestinal worms persist and are not expelled from the gut indicates 
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that they are able to evade these immune responses, although the 
mechanisms by which they achieve this are unclear.   
 The only important non-specific barrier to infection is hydrochloric acid, 
secreted as ions into the stomach lumen by the parietal cells in the gut wall.  
Although this acid can kill infectious stages of many potential pathogens, 
paradoxically it is also a necessary stimulus for the establishment of many 
parasites: exposure to acid is required for the excystment of Giardia 
duodenalis (al-Tukhi et al., 1991, Hautus et al., 1988) and may be a 
necessary stimulus for the eggs of Ascaris lumbricoides to hatch, along with 
warmth and exposure to bile salts.  But once in the intestine, the site where 
the worms come to maturity, all parasites of the gut have a body surface that 
is resistant to the action of the host’s digestive enzymes, while some worms 
have developed specific anti-enzymes (Uglem and Just, 1983), presumably 
for self-protection.  The role of anti-enzymes in causing malnutrition is putative 
rather than proven, and it seems most likely that they act locally to prevent 
damage to the worms’ surface by host enzymes, rather than being secreted to 
have a widespread effect in the gut and thus perhaps on human nutrition. 
The infectious stages of parasites have an easy way to enter their host, 
usually through the mouth as a contaminant of food, water or fingers, while 
the next generation leaves the body in faeces through the anus in the form of 
spores, cysts, eggs or larvae.  There are exceptions: a few parasites of the 
gut enter the body through the skin, notably the larvae of hookworms and 
Strongyloides stercoralis.   
The major problem for parasitic worms is to get from one host to 
another, a journey that is facilitated in several different ways:  
• by producing large numbers of infectious stages to increase the 
chances of infecting a new host; a fertilised female A.lumbricoides, for 
example, may produce up to 200,000 eggs a day (Sinniah, 1982), 
therefore millions in a life-time; 
• by producing resistant infectious stages that can withstand adverse 
conditions; the eggs of species of Ascaris can survive for several 
months or years in warm, humid and sheltered conditions 
(Gaasenbeek and Borgsteede, 1998), and are resistant even to 10% 
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formalin (Sandars, 1951) though not to exposure to ultra-violet light or 
to desiccation (Crompton, 1989); 
• by infecting an intermediate host in which the parasite both multiplies 
and is dispersed, a feature of the life-cycle of many trematodes, a 
group of flatworms whose species often reproduce in snails from which 
are released larval stages that are infectious to humans ; 
• by infecting or encysting on foods that are consumed by a new host 
(Fried et al., 2004); 
• by the behaviour of infected people that puts others at risk of infection, 
such as defecating in the open, so that infectious stages are spread in 
the environment (Kilama, 1989); 
• and the behaviours that put people at risk of infection, such as pica 
(Geissler et al., 1998); by using fresh human faeces (sometimes called 
‘nightsoil’) as a fertiliser (Needham et al., 1998, Pan et al., 1954); and 
by poor personal hygiene. 
 Because the gastro-intestinal ecosystem offers such a rich habitat it 
has been colonised by an enormous number of different species.   The next 
section introduces the major species of worms that live in the human gastro-
intestinal tract. 
 
1.2 Groups of intestinal parasitic worms that infect humans 
The variety of general and specific names given to worms can be quite 
confusing to a novice (see Box 1).  The terms ‘helminths’ and ‘worms’ are 
generic names for metazoan (multicellular) parasites that are classified by 
helminthologists into two main Phyla: 
• Nematoda: the nematodes or roundworms, such as Ascaris 
lumbricoides and Trichuris trichiura; 
• Platyhelminthes: the flatworms, which contain two important Classes of 
parasites of humans: 
o Trematoda: the flukes, such as Fasciolopsis buski and 
Metagonimus yokogawa; 
o Cestoidea, sub-class Eucestoda: the tapeworms, such as 
Taenia saginata and Diphyllobothrium latum. 
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Box 1   How worms are named 
Worms go under a variety of general and specific names derived from 
different languages, but mostly old English, Latin or Greek.  ‘Worm’ is 
derived from the old English word wyrm, meaning a snake or a dragon.  
‘Worm’ is also associated with the Latin vermis from which comes the 
English words vermicide and vermifuge, a drug for treating worms.  The 
generic term ‘helminths’ is an English word derived from the Greek word 
for worms, helmins.  From this root is derived the term anthelmintic 
(sometimes anthelminthic or antihelminthic), a drug to treat worms.  The 
name of the phylum Platyhelminthes combines the Greek terms platys, 
meaning broad or flat, and the word for worm.  The Platyhelminths include 
two groups: the tapeworms (Old English ‘tape’ meaning tape, combined 
with ‘worm’) or cestodes (derived from the Greek word kestos meaning a 
strap); and the flukes (Old English term derived from the name for a type 
of fish called a plaice or flounder, which the worms look like) also called 
trematodes (derived from the Greek word trema meaning orifice or hole 
and eidos, meaning ‘in form’).  The Phylum Nematoda (derived from the 
Greek nema, a thread, and eidos, meaning ‘in form’) are classified as 
helminths (but not Platyhelminths) as they are roundworms (derived from 
old French rond meaning round), not flat worms.  Each species has a 
name in Latin that is a noun (which takes an upper case first letter) 
followed by an adjective (which takes a lower case first letter).  For 
example the Latin name Ascaris lumbricoides is derived from the Greek 
word Askaris, meaning intestinal worm, and the Latin word lumbricus, 
meaning worm-like.  The worm was given its name in 1758 by Carolus 
Linnæus, the father of nomenclature, who apparently had not heard of 
tautology. 
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 Over 340 species of helminths have been recorded in association with  
humans (Coombs and Crompton, 1991) but most are rare zoonoses – 
infections of animals that can be contracted by humans.  Table 1 lists the 
names of the most common species of helminths that live in the human 
intestine.  The following section describes the life cycles of the most common 
species of intestinal flukes, tapeworms and roundworms. 
Insert Table 1 here 
1.2a Flukes or trematodes 
The two main species of intestinal trematode that infect humans listed in 
Table 1 are not widespread, although Fasciolopsis buski occurs focally in 
south-east Asian countries such as Thailand and the Philippines (Waikagul, 
1991) and in the Indian sub-continent (Gilman et al., 1982, Chandra, 1984).  
Fasciolopsis buski is a zoonosis, and usually infects dogs and pigs, two 
animals closely associated with humans (Mas-Coma et al., 2005).  A study in 
China reported an association between malnutrition and infection with flukes 
including F.buski, but the prevalence of this species was relatively low and the 
main pathogenic species was judged to be Schistosoma japonicum (Zhou et 
al., 2005). 
 Some 16 species of Echinostoma have been reported to infect humans 
(Carney, 1991, Huffman and Fried, 1990), which makes it the most common 
genus of intestinal fluke, but another seven species of gut flukes from a 
variety of Trematode families have been recorded including the Fasciolidae, 
Heterophyidae, Lecithodriidae, Microphallidae, Paramphistomatidae and 
Plagiorchiidae (Waikagul, 1991).  They are all zoonoses: infections of humans 
occurs by eating freshwater fish or shellfish, and the normal hosts are fish-
eating animals such as cats and birds.  Infections in humans are mainly found 
in adults in Asia who eat undercooked intermediate hosts such as crabs, frogs 
or fish, or in children who swallow metacercariae that have encysted on 
vegetation, such as water caltrop.   
 Infections with intestinal flukes are not common, even among adults, 
and are rarer still among children, so there is no known association with 
malnutrition. 
 The members of the order Schistosoma are not included in this review 
because they are not parasites of the intestinal lumen: they live in the portal 
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blood vessels around the gut (S.mansoni and S.japonicum) or urinary bladder 
(S.haematobium). 
 
1.2b Tapeworms or cestodes 
Of the most common tapeworms of humans, the three species of Taenia tend 
not to be found among children as they are transmitted by eating undercooked 
beef (T.saginata) or pork (T.solium = Taeniarhynchus solium and Taenia 
asiatica) (Macpherson, 2005, Eom and Rim, 1993).  These foods are not 
commonly eaten by poor children, or are proscribed in some parts of the 
world.  The adult worms live in the small intestine and release their eggs in 
packets called proglottides, a living section that breaks off the posterior end of 
a growing worm (Pawlowski and Schultz, 1972).  The proglottides of 
T.saginata are motile and can crawl away from a human stool deposited on 
the ground (see Figure 1), whereas the proglottides of T.solium do not show 
this activity.  This behaviour occurs because cattle do not eat human faeces, 
but pigs do.  When the eggs of Taenia species are swallowed by a suid or 
bovid species, they hatch, penetrate tissues and develop in muscles or organs 
to become infective cysticercoids.  Humans become infected by eating raw or 
undercooked beef or pork.  Infections can be common among people who 
habitually eat undercooked meat, such as ethnic groups that live in the Rift 
Valley of East Africa (Hall et al., 1981).  Because the eggs are passed in 
packets rather than loose in the faeces, infections can be missed during the 
microscopical examination of faecal samples (Hall et al., 1981). 
Insert Figure 1 here 
 The main concern for disease in humans is the possibility that the eggs 
of T.solium may hatch in the human intestine and develop in tissues to cause 
cysticercosis.  If this happens in the brain it can lead to epilepsy (Newell et al., 
1997).  When pigs infected with T.solium were given to appease guerrillas 
fighting the government in west New Guinea, there was an outbreak of 
cysticercosis.  This came to attention when people with severe burns 
appeared at hospitals: they had experienced an epileptic fit when sleeping 
next to a fire for warmth at night and had fallen into the flames (Gajdusek, 
1978).   
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 The effect of tapeworms in the intestine is minimal, probably because 
their relative mass is small in comparison with their host.  It is also thought 
that the presence of existing worms may perhaps inhibit the establishment of 
additional worms, though this is hard to prove without deliberately infecting 
people.  There is no known association between infections with Taenia spp 
and malnutrition in children. 
 Hymenolepis nana is a widespread parasite of children, but the 
reported prevalence rarely exceeds 20% and is usually less than 5% (Khalil et 
al., 1991, Mason and Patterson, 1994, Sirivichayakul et al., 2000). The worm 
can persist by means of autoinfection, a process in which eggs hatch and 
mature in the human gut to form adults, without passing into the environment 
in the normal way to infect an insect intermediate host. 
   Hymenolepis diminuta is usually a parasite of rodents, but it is found in 
children in situations in which they come into contact with rat or human faeces 
containing the worms’ eggs.   
 Both species of Hymenolepis are associated with malnutrition, in that 
they tend to occur amongst children living in poor and unhygienic 
communities, but there have been no studies looking at the impact of 
treatment to suggest that they cause malnutrition. 
 Diphyllobothrium latum is a notable tapeworm because it selectively 
absorbs vitamin B12 from the diet of its host or may interfere with absorption, 
which occurs only in the last third of the ileum; this can lead to pernicious 
anaemia (Nyberg, 1963).  Infections occur by eating raw freshwater fish 
containing a plerocercoid larva, and were once common in Scandinavian 
countries such as Finland (Raisanen and Puska, 1984).  This species has 
been reported all over the world, but mostly as curious case reports.  It is not 
a common cause of anaemia in young children mainly because fish is an 
expensive food, and in most communities it is not commonly eaten raw, 
especially by children. 
 
1.2c Roundworms or nematodes  
Of the six species of nematode worms listed in Table 1, Enterobius 
vermicularis is found worldwide but is rarely a cause of serious disease, and is 
more a cause of irritation.  The female worms lay their eggs around the anus 
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at night.  This causes itching and pruritis that may occasionally lead to peri-
anal sepsis in young children (Mahomed et al., 2003), probably because they 
scratch themselves.  Infections have been reported to cause enuresis (Otu-
Bassey et al., 2005) and are very rarely associated with appendicitis (Arca et 
al., 2004).   
 Enterobius vermicularis tends to be most common among very young 
children, especially in kindergartens or among children living in institutions, 
probably because their personal habits are not well developed and they are in 
close physical contact with other children (Remm, 2006, Song et al., 2003).  It 
is a difficult infection to diagnose efficiently because the eggs are not often 
seen in faeces, so it is necessary to press sticky cellophane tape over the 
peri-anal skin of a child, usually after a night’s sleep when the worms have 
laid their eggs, and examine the tape under a microscope (Celiksoz et al., 
2005).  The itching may affect a child’s sleep, but is not known to be a cause 
of malnutrition or poor growth.   
 Infections with Strongyloides stercoralis are also associated with poor 
hygiene, close contact between people, and a lack of sanitary facilities.  
Infections have been reported among children in nursery schools and among 
adults in psychiatric institutions (Braun et al., 1988, Gatti et al., 2000).  The 
worm can persist by a process of auto-infection in which larvae hatch in the 
large intestine and burrow directly into the gut wall, so emulating a naturally 
acquired infection (Schad, 1989).   
 Infections with S.stercoralis can be transmitted directly from person-to-
person by exposure to fresh faeces in the immediate living environment.  A 
study in Bangladesh found that infections with S.stercoralis in people living in 
an urban slum were associated with households that lacked a latrine and had 
an earthen floor which may help larvae to survive (Hall et al., 1994).   But 
when these factors were controlled for, the aggregation of infections may have 
been due not only to shared risk factors, but to a genetic predisposition that 
could also have contributed to infection (Conway et al., 1995).   
Although hyperinfections with Strongyloides stercoralis can be 
dangerous in immunocompromised patients (Keiser and Nutman, 2004), such 
as those being treated with immunosupressants (Schaeffer et al., 2004) or in 
the elderly, little is known about how many children are infected in the world 
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today, so the worm’s status as a cause of malnutrition and poor growth is 
unknown.   
 The four main nematode worms most commonly associated with 
malnutrition and disease in children are Ascaris lumbricoides, Trichuris 
trichiura and both species of hookworms, Ancylostoma duodenale and 
Necator americanus.  These worms are sometimes called soil-transmitted 
helminths.  As this term refers to their mode of transmission, the generic term 
intestinal nematodes will be used here, which infers direct consequences for 
human health, and is perhaps more informative. 
 Ascaris lumbricoides is the largest intestinal nematode worm to infect 
humans.  An adult female A.lumbricoides typically weighs between 4 and 7 g, 
but can weigh up to 9 g and grow as long as 40 cm.  Male worms are smaller, 
and weigh 2 – 3 g.  Adult worms usually inhabit the jejunum (Crompton, 1989) 
where they feed on intestinal contents, but worms may be found higher and 
lower in the gut when present in large numbers, perhaps because of 
competition for living space.  Worms may sometimes migrate into unusual 
sites such as the bile or pancreatic ducts, which they can block and cause 
acute and life-threatening disease (Ferreyra and Cerri, 1998, Sandouk et al., 
1997).  Adult A.lumbricoides  have a tendency to wander if irritated and worms 
have been extracted from the nose and Eustachian tube (Fagan and Prescott, 
1993, Jain and Pahuja, 1988). 
 Adult A.lumbricoides maintain their position in the intestine by 
swimming against the flow of food, and when they die, they are carried out of 
the body in the faeces.  Ascaris lumbricoides  is the only intestinal nematode 
worm that is easily seen and identified in faeces, and is the only species of 
nematode for which anthelmintic treatment is visibly successful.  This was the 
basis of a long-running Japanese family planning programme:a because the 
expulsion of A.lumbricoides from the gut offered manifest evidence of the 
effectiveness of treatment it provided an entry point to households to 
encourage women to use family planning.   
 An adult female A.lumbricoides may produce up to 200,000 eggs a day 
(Sinniah, 1982) in a life-span of 12 – 18 months (Anderson and May, 1991), 
                                            
a
 The Japanese Organization for International Cooperation in Family Planning (JOICFP) 
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but there is good evidence of both density dependent fecundity (Hall and 
Holland, 2000) as well as geographical variation in the number of eggs 
produced per female worm (Hall and Holland, 2000).  This means that worms 
produce fewer eggs when there are many present in the gut, and that there is 
not a linear relationship between the number of worms in a host and the 
concentration of eggs in faeces. The consequence is that the concentration of 
eggs in a faecal sample from a Bangladeshi child, for example, is not 
necessarily equivalent in terms of worm burden to the same concentration of 
eggs in a sample from an Iranian child (Hall and Holland, 2000).  As any given 
concentration of eggs in faeces may not reflect the same number of worms in 
different parts of the world, it means that the use of fixed ranges of egg counts 
to classify the intensity of infection with intestinal nematode worms is 
scientifically dubious.   This is discussed in more detail in Section 2. 
 Freshly excreted A.lumbricoides eggs are not immediately infectious 
and take 10 – 14 days to embryonate in the environment at 30 C, or about 50 
days at 17 C (Pawlowski and Arfaa, 1984).  This means that old faeces are a 
source of infection, not fresh faeces, and the soil on which they lie may no 
longer bear evidence of faecal contamination.  A new infection occurs when 
mature eggs are swallowed as a contaminant of food or fingers.  When an egg 
comes into contact with bile acids, the larva breaks out of the egg case and 
burrows through the intestinal wall.  After a few days migration through the 
blood stream to the liver and then to the lungs, the developing larvae break 
into the alveoli and are coughed up and swallowed.  Large numbers of larvae 
can cause a verminous pneumonia (Tomashefski et al., 1989, Valentine et al., 
2001, Gelpi and Mustafa, 1968).  The larvae pass through the stomach and 
into the small intestine for a second time, where they grow and mature to 
become adults.  Although this migration through tissues exposes the immune 
system to Ascaris antigens and stimulates an immune response, it does not 
seem to lead to protective immunity, at least not in all individuals, although 
some individuals may develop partial immunity  (see Section 2.4).  
 The adults of Trichuris trichiura live in the large intestine and caecum 
(Bundy and Cooper, 1989).  These nematode worms insert their whip-like 
anterior end into the gut wall and secrete enzymes and a specific protein that 
causes a syncytium to form (Drake et al., 1994), which provides an easily 
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ingested liquid food.  The penetration of the worm into tissues also causes 
inflammation and bleeding so that, when large numbers of worms are present, 
they can cause dysentery and even rectal prolapse (Bundy and Cooper, 
1989).  Each female worm produces 3,000 – 20,000 eggs a day (Bundy and 
Cooper, 1989).  The eggs mature in the environment to form an infectious 
larva within the egg shell in about 10 – 14 days.  When a mature egg is 
swallowed the larva hatches from the egg in the stomach and is propelled 
down the gut by peristalsis to the worm’s habitat in the large in intestine.   
 The two main species of hookworm that infect humans, Ancylostoma 
duodenale and Necator americanus, are usually considered together, for two 
reasons.  First, because they mostly now have an overlapping geographical 
distribution and occur worldwide, even if their origins were in the old and new 
world respectively.  Second, the eggs of each species cannot be told apart 
when examined under a microscope, so only a diagnosis of hookworm can be 
made.  It is necessary either to hatch the eggs and examine the larvae to tell 
which species is which, or to expel adult worms from the gut and recover them 
from the faeces.  Both of these procedures are difficult and the first carries a 
risk of infection. 
 The eggs of both species of hookworm are passed in the faeces.  A 
female A.duodenale is estimated to lay 10,000 – 25,000 eggs a day and a 
female N.americanus 5,000 – 10,000 eggs a day (Pawlowski et al., 1991).  
Again, like A.lumbricoides, the average number of eggs produced per female 
worm declines as the number of worms increases, a mechanism believed to 
contribute to the stability of worm populations (Bundy, 1990) but which may 
also serve to help prevent massive infections occurring.  Hookworm larvae 
hatch out onto the soil within 48 - 96 hours of being passed in the faeces, 
although the speed of maturation depends on the temperature and humidity 
(Smith, 1990).  The larvae do not feed, so have a finite life-span measured in 
a few weeks, again depending on the temperature, the degree of humidity to 
prevent desiccation, and whether the larvae are shaded from sunlight or not, 
such as by vegetation (Smith, 1990).  Hookworm larvae are thought to survive 
longest on light, sandy soil rather than on heavy, clay soil, and in places 
where the relative humidity is high (Mabaso et al., 2003).   
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 Infection with both species of hookworm occurs when the third stage 
larvae on the soil come into contact with bare skin.  The infectious larvae 
burrows through the epidermis by a process of mechanical penetration 
facilitated by secreted protease enzymes (Salafsky et al., 1990).  In large 
numbers this can cause an allergic reaction called “ground itch” (Gilles, 1990).  
Infections with A.duodenale can also occur if the larvae are swallowed 
(Schad, 1990).   
 Once in the human body, hookworm larvae migrate through the blood 
system and heart to the pulmonary blood vessels, where they bore into the 
alveoli.  The action of the cilia lining the bronchioles carries the larvae 
upwards, into the oesophagus, where they are swallowed, pass through the 
stomach, and reach the small intestine.  The worms take about 4 - 5  weeks to 
mature and start producing eggs, called the pre-patent period.  There is 
circumstantial evidence that larval worms may get into breast milk, because 
hookworm eggs have been seen in the faeces of infants too young to have 
been exposed to larvae (Schad, 1990).   
 The buccal cavity of both species of hookworms that infect humans 
contains sharp plates or ‘teeth’ used to grasp and cut gut tissue to enable the 
worms to suck up blood and tissue fluids (Roche and Layrisse, 1966).   Both 
species of hookworm secrete an anticoagulant to maintain the flow of blood 
(Roche and Layrisse, 1966, Hotez and Cerami, 1983).  It has been estimated 
that a single A.duodenale causes blood loss of 0.2 ml per day (range 0.14 – 
0.26 ml) compared with 0.04 ml per day (range 0.02 – 0.07 ml) by 
N.americanus (Roche and Layrisse, 1966).  When expressed in terms of the 
number of worms needed to lose 5 ml of blood each day, this corresponds to 
25 A.duodenale and 110 N.americanus (Pawlowski et al., 1991).  Some of the 
blood and iron ingested by hookworms is excreted into the host’s gut, and is 
available for absorption lower down the intestine.  It has been estimated that 
as much as 40 – 60% of the iron lost into the gut may be reabsorbed by 
anaemic people (Roche and Layrisse, 1966).   Whether or how quickly any 
given individual develops anaemia will depend on five factors: the number of 
worms; the duration of infection (see Section 2.3); the initial haemoglobin 
concentration; the size of the existing reserves of iron in the bone marrow; 
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and, most importantly, the amount and bioavailability of iron in the diet 
(Crompton and Whitehead, 1993, Gilles, 1990).  
  
1.3 How worms may affect human nutrition and growth 
There are several mechanisms by which intestinal nematodes could affect the 
nutritional status of their host: 
• By feeding on the contents of the host’s gut, including the host’s 
secretions that make up the exoenteric circulation; 
• By feeding on host tissues, including blood and serum, that leads to a 
loss of iron and protein; 
• By causing maldigestion or malabsorption of nutrients; 
• By inflammatory responses that lead to the production of substances 
that may affect appetite and food intake, or substances that modify the 
metabolism and storage of key nutrients such as iron; 
• And through contingent responses to infection, such as fever, leading 
to an increased metabolic rate; by causing hypertrophy of muscles; 
and by immune responses to infection, all of which result in the 
diversion or use of nutrients and energy for purposes that would not 
have been necessary had worms not been present. 
 All intestinal parasites obtain their nutrients either from the food and 
intestinal secretions of their host, or from their host’s tissues and body fluids.  
The nutritional needs of parasites are relatively small compared with a well 
nourished host, mainly because their relative biomass is small (see Box 2).   
This means that worms such as A.lumbricoides only take a relatively small 
proportion of the host’s food from the gut.  A study of tapeworms in protein 
malnourished rats indicated that the amount of protein in worms was only 
about 1% of the total protein intake, even if there were enough worms to fill 
the small intestine (Hall, 1983).  Although worms do not have an aerobic 
metabolism and are relatively wasteful of substrates to generate energy, it is 
also likely that the worm’s excretory products are absorbed, metabolised and 
excreted by the human host.  
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Box 2  The nutrition of worms 
 
There is a common belief that worms make children thin by consuming the 
food in their intestine or that they increase children’s weight by their 
presence.(SC/UK, 2004)  This is a fallacy because the biomass of worm 
tissue is relatively small in comparison with the biomass of an infected 
child.  For example a female Ascaris lumbricoides, which is the largest 
intestinal nematode worm that infects humans, has an average weight of 
some 3.2 g and a maximum of 9.0 g.  Male worms are half the size.   A 
study of the worm burdens of 268 infected children aged 4 – 10 years old 
found an average of 23 A.lumbricoides per child which weighed an 
average of just under 50 g.  This was 0.3% of the average weight of the 
children.  If 70% of the weight of worm tissue is metabolically active 
(excluding the chitinous exoskeleton and the pseudocoelomic fluid), and if 
the metabolic rate and need for energy of the worm is the same as its 
homeothermic host (77 kcal/kg/day), then a biomass of 50 g would require 
about 2.7 kcal of energy a day.   As helminths have an anaerobic 
metabolism which only generates about 5% of the energy as aerobic 
metabolism, this biomass of worms would require some 54 kcal, equivalent 
to 13 g of glucose, a day.  However as the metabolic by-products of the 
worm’s metabolism are likely to be absorbed and metabolised by the host, 
in whom they could produce energy, the inefficiency of energy production 
by worms may be mitigated.  Some unique metabolites of A.lumbricoides 
can be detected in human urine in proportion to the number of worms in 
the host (Hall and Romanova, 1990).  These rough estimates indicate that 
the nutritional needs of most worm burdens are small in relation to a child 
host, though during a severe shortage of food, the loss of any nutrients to 
a moderate or large worm burden may exacerbate undernutrition. 
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 The impact of worms’ nutritional requirements may be more significant 
to a host if the worms feed directly on host tissues, because the physical 
damage they do may have important consequences, in addition to the effects 
of nutrient losses due to feeding.  For example when hookworms move from a 
site at which they have been feeding, it may continue to bleed into the gut as 
a result of the persistent effects of the anticoagulant secreted from the worm’s 
salivary glands (Hotez and Cerami, 1983).  Moderate to heavy infections with 
hookworm are strongly associated with anaemia (Roche and Layrisse, 1966) 
which has consequences for growth (Stephenson et al., 1993a), physical 
fitness (Stephenson et al., 1993a, Latham et al., 1990b, Stephenson et al., 
1990) and worker productivity (Gilgen et al., 2001, Selvaratnam et al., 2003, 
Hunt, 2002). The feeding of hookworms can also cause a loss of blood 
proteins and the development of hypo-albumenaemia (Gilles, 1990).    
Maldigestion and malabsorption may occur as a result of physical 
damage to the gut surface.  The presence of moderate burdens of Ascaris 
suum in experimentally infected pigs has been shown to cause flattening of 
villi as well as villous atrophy and fusion (Martin et al., 1984), all of which 
could lead to a loss of brush border enzymes and a reduced surface area for 
digestion and absorption.  
 Damage to villi might be expected to lead to the loss of lactase.  A 
study of African children infected with intestinal parasites, including 
A.lumbricoides, did not find evidence of lactose malabsorption (Gendrel et al., 
1992) although this may be a result of a failure of the study to take into 
account the worm burden (see Section 2.3).  Another study, of Panamanian 
children, did find differences between groups of infected and uninfected 
children in the results of hydrogen breath tests, an indicator of lactose 
malabsorption (Carrera et al., 1984).  
 Another possible cause of malabsorption could be bacterial overgrowth 
of the small intestine due to the presence of worms, though this is more 
commonly associated with infections such as Giardia duodenalis (de Boissieu 
et al., 1996, Farthing, 1993, Müller and von Allmen, 2005, Tandon et al., 
1977).  
 A loss of appetite has been reported as a consequence of worm 
infections (Easton, 1999, Symons, 1985, Hadju et al., 1996) but it is hard to 
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study, because it would mean leaving some infected children untreated while 
others were given an anthelmintic.  However several studies have measured 
improvements in the appetite of children after treating worms (Hadju et al., 
1996, Latham et al., 1990b, Stephenson et al., 1993a), which has provided 
quite convincing evidence of an important  mechanism by which worms can 
impair children’s nutrition and growth.   
 The contingent responses to infection, which have been described in a 
previous review (Hall, 1985), lead to a waste – or at least an unnecessary 
diversion – of resources as a result of the physical and immunological 
responses to infection.  These are hard to quantify in humans, so 
experimental animals are often used.  For example, experimental infection of 
pigs with moderate numbers of A.suum, a species very similar to 
A.lumbricoides that can also infect humans, has been shown to lead to an 
increase by 50 – 100% in the wet weight of the small intestine compared with 
uninfected controls, mainly due to hypertrophy of the tunica muscularis 
(Stephenson, 1987).  This is likely to be in response to the need for increased 
muscularity to push food past worms in the small intestine by peristaltic 
contractions.  Histological cross-sections of the mucosa also show changes in 
tissues in addition to the flattened villi described above: the lamina propria 
becomes infiltrated with mast cells and eosinophils as a result of immune 
reactions to the presence of worms in the intestine, while goblet cells show 
hyperplasia as a result of producing more mucus, perhaps to try to protect the 
villi from erosion (Stephenson, 1987, Stephenson et al., 1980a).  These may 
be usefully adaptive and protective responses to infection, but they represent 
a diversion of nutrients that should not be necessary and could be better used 
for growth if they happen in an already undernourished child.   
 
1.4 Design of studies to estimate the impact of worms 
The main problem with studying the impact that worms have on child growth 
and nutrition has been touched upon in the previous section: the need for 
untreated controls.  If worms impair growth, and if treating worms leads to 
extra or catch-up growth, then it is necessary to measure the difference that 
treatment makes between treated and untreated subjects, not just the 
absolute amount of growth that occurs after treatment.  This is because some 
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amount of growth and weight gain should occur naturally in all children, unless 
they are severely undernourished or have a hormonal disease.   
 It could be argued that it is enough to express weight gain as a change 
in proportion to a reference value, such as a higher z-score of weight-for-
height, or a greater percentage of the median value.  But such improvements 
in anthropometric status could occur as a result of secular changes in the food 
supply, or as a result of better health because of seasonality in the 
transmission of other diseases, such as malaria and diarrhoea.  Concurrent 
and untreated controls are essential to the validity of the conclusions of any 
study of the impact of treating intestinal worms on child growth and nutritional 
status and are an important criterion for including any study in a meta-
analysis. 
  
1.5 Aims  
The aim of this review is:  
• To describe the epidemiological factors that influence the impact that 
intestinal worms have on human nutritional status and growth; 
• To describe the factors that affect the impact of anthelmintic treatment; 
• To undertake a meta-analysis of the effects of intestinal worms on 
children’s nutritional status and growth. 
 
 
2. Factors affecting the impact of intestinal worms 
In order to understand the impact that intestinal nematode worms have on the 
nutritional status and growth of children by any of the mechanisms proposed 
in Section 1, it is necessary to understand the factors that are likely to 
influence the degree or magnitude of their effects. 
 
2.1 Species of intestinal worm 
The most important species in terms of disease are Ascaris lumbricoides, 
Trichuris trichiura and the hookworms.  These worms live in different parts of 
the intestine, differ in the route they take to reach their adult habitat, and feed 
in different ways.  This has been described in Section 1.2.   
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 Although A.lumbricoides is undoubtedly the most common species 
worldwide, it is very hard to distinguish from A.suum (Crompton, 1989).  It is 
quite likely that both species occur together, especially in places where pigs 
are allowed to roam freely in their search for food in an environment inhabited 
by people (Maruyama et al., 1997, Kofie and Dipeolu, 1983).   
 Although the two hookworm  species are considered together because 
there is no easy way to tell them apart, there is evidence that A.duodenale is 
more pathogenic than N.americanus because it consumes more blood per 
worm (Roche and Layrisse, 1966).  As well as measurements of blood loss 
using radioactive isotopes (Roche and Layrisse, 1966), there is 
epidemiological evidence from a study of schoolchildren in Pemba, a small 
Tanzanian island where both types of hookworms occur, that in schools where 
the prevalence of A.duodenale is high there may be more anaemia and iron 
deficiency than in schools where N.americanus is the predominant species 
(Albonico et al., 1998).   
 The conclusion is that different species will have different effects on the 
nutritional status and growth of children. 
 
2.2 Prevalence of infection 
The first important epidemiological parameter that describes the potential 
effect of worms on human health is the proportion infected, or prevalence.  
Infections are usually diagnosed by seeing the characteristic eggs of each 
species of worm in faeces examined under a microscope, which simply 
indicates that there is present in the gut at least one sexually mature female 
and one male worm.  The exception is A.lumbricoides, because unfertilised 
female worms can produce infertile or “decorticated” eggs; they can be 
identified because they are longer and narrower than fertilised eggs 
(Crompton, 1989, WHO, 1994a).   
 Infections with intestinal worms may therefore be missed if there are 
only female worms present, or only male worms, or only immature worms.  
Such infections are not clinically important, but they will lead to an 
underestimate of the prevalence   
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 Infections may also be missed if an insensitive method of diagnosis is 
used, such as a direct faecal smear, and if the concentration of eggs in faeces 
is low.  A study in Bangladesh found that some 8% of infections with 
A.lumbricoides were missed when infections were diagnosed using a 
moderately sensitive ether sedimentation method (Hall, 1981) and compared 
with a diagnosis made by expelling worms using an effective anthelmintic drug 
(Hall et al., 1999).   
 Table 2 shows the range in numbers of eggs estimated to be produced 
daily by a female worm of each species.  They suggest that the sensitivity of 
diagnosing a light infection of a few worm varies between species, probably in 
the rank order A.lumbricoides, A.duodenale, T.trichiura and lastly 
N.americanus. 
Insert Table 2 here 
   Infections with the three main types of intestinal worms number among 
the most common infections of children in the world today.  Table 3 presents 
some recent estimates of the numbers of people infected with A.lumbricoides, 
T.trichiura and the hookworms, by age range.  Table 4 presents recent 
estimates of the prevalence of these infections in young school-age children, 
aged 5 – 9 years.  This age group is particularly likely to have moderate to 
heavy infections and is vulnerable to their impact on nutritional status.   
Insert Table 3 here 
Insert Table 4 here 
 Figure 2 shows the typical relationship between age and the 
prevalence of infection with A.lumbricoides derived from a study of people 
living in an urban slum in Bangladesh; a similar relationship is commonly 
observed for T.trichiura.  Figure 2 indicates that infections are acquired in the 
first two years of life and that around 80% of all age classes are infected, a 
high but typical proportion. 
Insert Figure 2 here 
 Hookworms tend to show a different pattern in which the prevalence 
typically increases with age, reaching a peak in late adolescence and 
adulthood (Bundy et al., 1992a).  The reason for this difference is not clear, 
especially as children are less likely to wear shoes than adults and so could 
be considered to be more to be exposed to hookworm larvae on the soil.  But 
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the differences in prevalence may reflect where worms are transmitted in what 
have been called “domains of infection” (Cairncross et al., 1996).  The 
transmission of both A.lumbricoides and T.trichiura is thought to occur within 
or around the household, in the domestic domain, while hookworms may be 
transmitted beyond the household, in the public domain which is frequented 
more by adults than children (Cairncross et al., 1996).   
 Although the prevalence of infection in children may provide some 
indication of the importance of each worm in terms of health and nutrition, 
there is no clear threshold prevalence associated with disease, largely 
because the relationship between prevalence and the intensity of infection is 
strikingly non-linear.  Figure 3 shows the relationship between the prevalence 
of infection with intestinal worms and the worm burden, derived from data 
collected in Bangladesh on A.lumbricoides (Hall et al., 1999).  It can be seen 
that, below a prevalence of about 50%, the mean worm burden is relatively 
low, but rises almost exponentially above a prevalence of 60%.  This means 
that even a prevalence of up to about 50% is associated with a low average 
worm burden, and that the prevalence of infection is a poor indicator of the 
probability of disease unless it is 70% or greater.   This relationship helps to 
explain the use of a threshold prevalence of 50% for administering mass 
anthelmintic treatment for both soil-transmitted helminths and schistosomiasis, 
a threshold that was endorsed by a WHO Expert Committee in 2001 (WHO, 
2002a).  This threshold has subsequently been lowered by the WHO to 20% 
for mass treatment once a year in what they classify as “low risk” 
communities, and the WHO now apply the 50% threshold to define a “high 
risk” community where mass treatment twice a year is warranted (WHO, 
2006).  
Insert Figure 3 here 
 The relationship between prevalence and disease is further 
complicated by the mix of species: in many parts of the world it is common to 
find all three major types of worms together, so that some children have two 
or three infections.  Although the prevalence of A.lumbricoides  and T.trichiura 
is often correlated (Booth and Bundy, 1992), it seems that an infection with 
one species does not predispose to the presence of another.  Figure 4 shows 
a diagrammatic representation of the percentage of individuals who have 
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multiple infections when the prevalence of A.lumbricoides  is 60%, T.trichiura 
is 50% and the hookworms is 40%, all arbitrary but typical figures.  If the 
probability of having one infection is independent of having another, then it 
can be estimated that 32% of individuals have at least two infections and 18% 
have all three infections (Figure 4).   
 There is no method to assess the impact of multiple infections: they 
could be additive but might be multiplicative or even antagonistic if species 
occur in the same location in the gut, such as A.lumbricoides and the 
hookworms.   As multiple infections may be as common or more common 
than single infections, it is hard to estimate the relative benefit of treating each 
different species, especially as the drugs used to treat intestinal nematode 
worms are effective against all species, if to differing degrees (see Section 
3.2).  
 In conclusion the WHO threshold of 50% infection provides a 
reasonable basis for applying mass treatment.  Below this threshold few 
people have moderate to heavy worm burdens that cause disease and the 
majority are uninfected; above this threshold the likelihood of moderate to 
heavy infections increases exponentially.  This is not to say that worms do not 
cause disease below a prevalence of 50%, but the effect on a very small 
minority may be lost in the group average.  A prevalence of 50% was taken as 
a minimum for studies of deworming to be included in the meta-analysis 
reported below, and studies such as those of (Garg et al., 2002) in which the 
prevalence of infection with any worm before treatment with an anthelmintic 
was only 11%, were excluded.  This threshold may seem somewhat arbitrary, 
but it is based on the relationship shown in Figure 3 and it would be unusual 
to include any uninfected individuals in a trial of a drug to treat a bacterial 
diseases.  A prevalence of 50 – 100% represents a typical range in many 
human communities in which mass anthelmintic treatment is given, and the 
effectiveness of treatment in such studies represent common epidemiological 
circumstances.   
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2.3 Number and distribution of worms  
Each worm that becomes established in a host represents the successful 
hatching, migration, establishment and development of a single fertile egg.  
Nematode worms do not multiply within their host, except for Strongyloides 
stercoralis (see above) the eggs of which can hatch within the lower bowel to 
release infective filariform larvae that penetrate the gut wall in a process 
called auto-infection (Schad, 1989).  This explains the persistence of 
S.stercoralis in British soldiers who were prisoners of the Japanese in Asia 
during the second world war and who have developed strongyloidiasis in their 
old age (Gill and Bell, 1979, Gill and Bell, 1987, Gill et al., 2004).  
 For each of the four major types of intestinal worms the probability of 
disease is related to the number of worms in the host, called the worm 
burden.  Figure 5 shows the average number of A.lumbricoides recovered 
from males in 11 age classes in an urban slum in Bangladesh who were given 
a drug that paralysed their worms so that they were expelled by peristalsis, 
then recovered, washed and counted.  It shows that the heaviest average 
infections were found in school-age children from 5 – 15 years old, a 
characteristic typical of many helminth infections. The notable exception is the 
hookworms, for which the prevalence and mean worm burden tend to 
increase with age so that adolescents and adults tend to be most heavily 
infected (Bradley et al., 1992, Bundy, 1990). 
Insert Figure 5 here 
 There are two theories to explain the shape of the distribution in 
Figure 5.  First, it could reflect differences in behaviour, because children are 
more exposed to worm eggs than adults, perhaps as a result of playing on 
faecally contaminated ground and poor personal hygiene.   
Second, it could reflect the development of a partially effective immune 
response to infection, or perhaps a more effective immune response in some 
individuals than others as a result of repeated exposure to worm larvae.  The 
study in Bangladesh however found a statistically significant difference in the 
mean worm burden of A.lumbricoides between adult males (who leave their 
community to work during the day) and adult females (who stay at home in the 
crowded, unsanitary environment), which suggests that exposure more than 
immunity influences this distribution (Hall et al., 1999). 
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 When the distribution of worms among hosts is examined it is typical to 
find that it is highly skewed, so that most individuals have light infections while 
a minority have moderate to heavy infections.  Figure 6 illustrates this 
distribution using data on the number of A.lumbricoides recovered from 1,765 
people who were treated with pyrantel pamoate to paralyse and expel their 
worms.  The distribution shown in Figure 6 is best described by the negative 
binomial, which is purely an empirical fit, and implies nothing about the 
biological reason why worms should be distributed in this way.  But this 
distribution, which is described as aggregated or over-dispersed, is typical of 
most helminth infections and has been observed even in pigs each of which 
have been infected experimentally with the same number of fertile eggs of 
A.suum (Boes et al., 1998, Stephenson et al., 1980a).  This suggests that the 
distribution derives from differences between hosts in the establishment of 
worms rather than in differences in exposure to eggs. 
Insert Figure 6 here 
 The equation that describes this distribution is defined by three 
parameters, the prevalence (P), the arithmetic mean worm burden (M), and by 
(k), a parameter that varies inversely with the degree of aggregation or 
clumping of worms in a few hosts so that: 
 P = (1 – (1 + M/k)-k) 
 * 100 
 The parameter k captures the degree to which worms in a small 
proportion of hosts tend to be aggregated, clumped or over-dispersed (terms 
commonly used in this context).  Small values of k, typically less than 1, 
indicate a high degree of aggregation of worms, irrespective of age, sex or 
any other factor.  The study in Bangladesh indicated that k varied with the 
mean worm burden so that, as the mean burden increased, the degree of 
aggregation decreased (Hall et al., 1999).  The implication is that, when the 
average worm burden is large, more people are likely to have moderate to 
heavy infections and may be diseased as worms are less aggregated.  Figure 
7 shows the cumulative percentage of all worms recovered from 1,765 people 
in urban Dhaka plotted against the cumulative percentage of hosts, for worm 
burdens between zero and 187 worms.  It shows that a half of all subjects 
expelled only 10% of all worms, and that 80% of all subjects contained only 
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40% of all worms.  The remaining 60% of worms were recovered from only 
20% of individuals. 
Insert Figure 7 here 
 If it is typical to find that a small proportion of people harbour a large 
proportion of worms, what happens when they are treated?  Evidence from 
studies of reinfection after treatment have found that heavily infected 
individuals tended to become heavily reinfected again while lightly infected 
people become lightly reinfected, leading to the theory that some individuals 
are predisposed to infection and others are not (Bundy and Cooper, 1988, 
Chan et al., 1994, Forrester et al., 1990, Haswell-Elkins et al., 1987, Holland 
et al., 1989, Kightlinger et al., 1995).  If this is so, could efforts be 
concentrated on the individuals who were predisposed to worms?  This was 
examined in a study of infection and reinfection with A.lumbricoides in 880 
individuals in Bangladesh (Hall et al., 1992).   It was found that, although there 
was evidence of a predisposition to moderate to heavy infections, over three 
rounds of treatment and two periods of reinfection of 6 months, about two 
thirds of all subjects were moderately or heavily infected at least once (Hall et 
al., 1992).  This suggested that there was no benefit in identifying moderately 
to heavily infected people on the assumption that they were predisposed 
individuals, and mass treatment should be given rather than any form of 
selective treatment.   
 The biological implications of the aggregation of worms are that most 
individuals in a community at any one time have light infections, but a minority 
ranging from < 1 – 40% will have moderate to heavy infections and are most 
likely to be diseased.  If treatment is given periodically and reinfection occurs 
(which will happen because eggs can persist in the environment for many 
months, if not years), then over a period of 2 – 3 years a majority of 
individuals will be moderately to heavily infected at some point.  This has 
implications for measuring the impact of mass treatment, as a minority will 
benefit more than the majority in the short term, but over a longer period of 
periodic treatment, an increasingly larger proportion will benefit. 
 A light infection probably has little effect on the nutritional status of a 
host, and the worm burden is the key indicator of the probability of disease.  
This requires that worms are expelled and counted, something that is difficult 
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to do, and it destroys the worm burden at the same time, so that infected 
subjects can no longer be followed. So in most surveys of worms the 
concentration of eggs in faeces is used as an indicator of the intensity of 
infection.  However the perception of egg counts tends to be relative, so that 
what is seen to be a moderate egg count in one place could be considered to 
be high or even low in another.  To provide some guidance on assessing egg 
counts a WHO Expert Committee in 1987 suggested threshold egg counts to 
classify light, moderate and heavy infections with A.lumbricoides and 
T.trichiura (WHO, 1987).  In 2002 a new Expert Committee added hookworm 
to the list although the previous committee had stated that egg counts for this 
worm could not be given because the “critical worm load differs locally 
depending on age, sex, iron intake and species of hookworm” (WHO, 2002a).  
These thresholds are shown in Table 5. 
Insert Table 5 here 
 Since the Expert Meeting in 1987 it has been clearly shown for 
A.lumbricoides at least, that the relationship between worm burden and egg 
count is both non-linear and differs between worms in different countries (Hall 
and Holland, 2000).  For example 20 worms was associated with around 
1,300 eggs/g of faeces or 2,300 egg/g in two studies in Bangladesh, with 
17,300 eggs/g in Iran, with 22,000 eggs/g in Nigeria and Madagascar, with 
27,000 eggs/g in Burma, and with 44,500 eggs/g in Mexico (Hall and Holland, 
2000).  This indicates that there is no consistent relationship between egg 
counts and worm burdens that can be applied universally, for A.lumbricoides 
at least. 
 
2.4 Duration of infection 
One of the main factors besides the worm burden that is likely to contribute to 
the development of disease is the duration of infection, something that is not 
usually known.  Table 6 shows the estimated life span of the major species of 
intestinal nematodes of humans. 
Insert Table 6 here 
 But even if a worm such as A.lumbricoides can live for as long as two 
years and is then expelled from the gut when it dies, new worms are 
continually acquired so that people remain persistently infected with slowly 
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changing numbers of worms.  Figure 2 indicates that just over 60% of children 
aged 1 – 2 years in the study in Bangladesh were infected with A.lumbricoides 
and Figure 5 indicates that they contained an average of about 7 worms.  As 
both the prevalence and mean worm burden are higher in older age groups, it 
suggests that most people are infected throughout their life.   
 
2.5 Rate of reinfection 
If the population of worms in a community of hosts is perturbed by giving 
mass treatment with an anthelmintic, reinfection can occur immediately and 
the number of worms will rebound to a similar number as before, a state 
called equilibrium.  Without treatment there may be fluctuations in time in the 
numbers of worms in individuals as some die and others are gained, but the 
number of worms in the community seems to reach a relatively steady state, 
perhaps driven by factors such as sanitation, the contamination of the 
environment, behaviours that put people at risk, and environmental conditions 
that favour the survival of infectious stages.  Figure 8 shows the prevalence of 
infection with A.lumbricoides in 880 people at three rounds of treatment, six 
months apart and Figure 9 shows the mean worm burden on the same 
occasions (Hall et al., 1992).   
Insert Figure 8 here 
Insert Figure 9 here 
 The prevalence, shown in Figure 8, rebounded very quickly after 
treatments in the school-age children, perhaps because the force of infection 
was greater in this age class, but was lower at each round in the four adult 
age classes.  The mean worm burden shown in Figure 9 was, however, lower 
at each round of treatment in all age classes except for the very youngest 
cohort, whose exposure to worm eggs probably increased as they became 
mobile and were increasingly exposed to worm eggs.  Figures 8 and 9 show 
that periodic treatment may do little to perturb the prevalence of infection but, 
if given often enough, it can help to prevent reinfection with the same number 
of worms.  In an environment such as an urban slum in Bangladesh, it may be 
necessary to give treatment for worms at least three times a year rather than 
twice annually, in order to sustain low worm burdens and reduce the 
probability of disease.   
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 Figures 8 and 9 also illustrate that the prevalence is a poor indicator of 
the effectiveness of worm control by periodic deworming, and that an indicator 
of the intensity of infection is better (Bundy et al., 1992a).  Ideally both should 
be measured during a programme of mass deworming. 
 
2.6  Summary 
The probability that an infected child has disease or malnutrition caused by 
intestinal worms is related to: 
• The species of worm;  
• The mixture of species;  
• The worm burden of each species. 
• And the duration of infection before treatment. 
 The number of worms is difficult to assess without expelling them from 
the gut.  The concentration of eggs in faeces may only represent a worm 
burden in a specific locality, because fecundity varies with the number of 
worms and perhaps between strains of worms in different locations around the 
world.  There are no threshold numbers of worms to classify burdens as light, 
moderate or heavy.  There are no methods to combine the probability of 
disease due to different numbers of worms of different species in the same 
individual. 
 
 
3. Factors affecting the impact of treatment 
Section 2 has described how the biology of each species of worm and the 
distribution of worms among hosts is likely to influence the effect that they 
have on the growth and nutritional status of children.  As it is unethical to 
infect children with worms and measure prospectively their impact on growth, 
evidence of the effect of worms on humans comes either from cross-sectional 
surveys or from experimental studies in which changes in key indicators of 
health, growth and nutrition are measured after giving treatment.    
 Cross-sectional studies are difficult to interpret.  Although several have 
shown an association between infections with intestinal worms and 
undernutrition or stunted growth (Moore et al., 2001, Muniz et al., 2002, Al-
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Mekhlafi et al., 2005, Gupta, 1990, Saldiva et al., 1999, Egger et al., 1990, 
Cerf et al., 1981), other studies have not (Pegelow et al., 1997) or have had 
mixed results (Mahendra Raj et al., 1997b).  The best analysed studies have 
controlled for factors such as age, sex and socio-economic status, and have 
examined associations not just with the presence of infection, but with an 
estimate of the intensity of infection.  The main problem with doing such 
analyses lies in the lack of data on the actual worm burden rather than on egg 
counts, which do not have a consistent relationship with worm burden, and 
with quantifying the combined effects of more than one species of worm.  
 There is also considerable potential for publication bias in cross-
sectional studies because only interesting and biologically plausible 
associations are likely to be written up and submitted for publication, while 
negative findings are either not submitted or are less likely to be accepted by 
a scientific journal. 
 But the main scientific problem with cross-sectional studies is related to 
temporality: did malnutrition predispose children to infection with worms, or did 
worms cause the malnutrition?  It is also unlikely that worms, and only worms, 
are responsible for all undernutrition or stunted growth.  Worms are 
associated with poverty and a poor diet, so if worms have a harmful effect, it is 
likely to be in addition to underlying chronic malnutrition.  
 Second, infection with worms reflects exposure to human faeces, a 
waste material that contains many other pathogens in addition to worm eggs, 
such as viruses, bacteria and protozoa.  Repeated episodes of diarrhoea and 
other infectious illnesses associated with living in an impoverished and 
unhygienic environment can also affect nutritional status through their effects 
on appetite, absorption and metabolic rate, as the studies of Mata and 
colleagues in Guatemala vividly demonstrated (Mata, 1978).  Infection with 
worms is an indicator of life in an environment contaminated with human 
faeces.   
 These complexities mean that it is not adequate simply to compare the 
growth of a group of infected children after treatment with a control group who 
were not infected with worms (Mahendra Raj et al., 1997a, Mahendra Raj and 
Naing, 1998), nor is it adequate to explain the magnitude of weight gain after 
treatment in terms of prior egg counts (Stephenson et al., 1980b).   
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 The need for untreated controls is reinforced when it comes to 
measuring the impact of treatment on weight gain or growth.  Even when 
children are chronically undernourished, some growth can be achieved, so 
without a control group it is not possible to know whether a treatment has led 
to extra weight gain or extra growth over any given period.   Making 
comparisons with a reference population to assess the degree of change in 
undernutrition will not provide an answer either.  Even if an improvement in 
anthropometric indices is recorded, or a fall in the percentage of children who 
are in some way undernourished, such changes can occur as a result of 
secular improvements in food supply or a decrease in the transmission of 
other diseases such as malaria or diarrhoea over the period of a study. 
 This section describes factors that influence the impact of treatment on 
children’s growth and nutritional status.   
 
3.1 Study design: controls and randomisation 
In order to estimate reliably the magnitude and statistical significance of the 
effect of a treatment on growth or nutritional outcome it is necessary to have 
an untreated control group (Stephenson, 1987).  To ensure that naturally 
occurring differences between subjects are evenly distributed between groups 
before treatment is given, individuals also need to be randomly assigned to 
each study group.  As there can be large differences between individuals in 
the intensity of infection because of the aggregated distribution of worms, if 
the sample size is small then subjects may need to be stratified first by egg 
count, before random allocation.  If the sample size is large and the 
prevalence is high, then random allocation is likely to be sufficient.    
 If the treatments are allocated by clusters, such as villages or schools 
rather than to individuals, there must be a sufficient number of clusters to 
distribute any variation between clusters in the prevalence and intensity of 
infections evenly between study groups.  Randomised cluster designs have 
the potential to provide the large sample sizes that are needed to be able to 
detect the effects of treatment on the minority of subjects who will benefit most 
from treatment. 
 Ideally all subjects in a control group in a simple randomised trial 
should be given an identical placebo.  This is less easy to do in cluster 
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randomised trials, especially if anthelmintics are given through the health 
system.  Effectiveness trials, such as the one done as a part of Child Health 
Fairs in Uganda (Alderman et al., 2006), typically have untreated controls, but 
they usually receive nothing rather than a placebo.  This opens the study to 
potential bias because of self-treatment with anthelmintics among the control 
group. 
 
3.2 Anthelmintic drugs and other treatments 
The drugs used to treat infections with intestinal nematodes can be divided 
into two main types:  
• Drugs that act on the nervous system to paralyse worms so that they 
are expelled from the gut by normal peristalsis, such as piperazine, 
levamisole and pyrantel pamoate;  
• Drugs that inhibit metabolic processes, such as the benzimidazole 
derivatives albendazole, mebendazole and tiabendazole, which block 
the uptake of glucose by microtubules in the mitochondria of worms 
(Horton, 2002, Horton, 2000), and the relatively new treatment 
nitazoxanide, which acts in protozoa by inhibiting the enzyme pyruvate 
ferredoxin oxidoreductase (Esposito et al., 2005, Sisson et al., 2002, 
White, 2003). 
There are differences between these types of drug in the efficacy with 
which they treat each species of intestinal worm (de Silva et al., 1997).  
Efficacy is assessed in two ways:  
• As the cure rate, which is the percentage of infected subjects in whose 
faeces worm eggs are no longer found after treatment (although some 
immature female or male worms could still remain, thereby over-
estimating the cure rate); 
• As the egg reduction rate, which is the percentage reduction in the 
arithmetic or geometric mean concentration of eggs in the faeces of 
infected individuals.  The concentration of eggs reflects the number of 
female worms, and an even sex ratio is usually assumed. 
 The cure rate and egg reduction rate are typically estimated by 
collecting and examining under a microscope a faecal sample collected a few 
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days before treatment and then again some 14 – 21 days afterwards.  The 
gap after treatment is advisable because there is evidence that the drugs may 
temporarily inhibit egg production by worms that have survived treatment (Hall 
and Nahar, 1994).    
 Because of their different modes of action the two types of anthelmintic 
drugs differ in their efficacy: drugs that paralyse worms tend to be less 
effective than those that inhibit metabolic processes, perhaps because the 
paralysis can wear off more quickly than the effects of a metabolic inhibitor, 
especially if worms are anchored to the gut wall.  (If A.lumbricoides are 
expelled from the gut using a drug such as pyrantel or levamisole and placed 
in warm saline, they can recover their motility after a few hours, showing the 
transitory effect of the paralysis). 
 Table 7 gives a rough guide to the range in efficacy of each type of 
drug against the main species of intestinal nematode worms at the usual 
dosage given.  Data are generally lacking for the drugs that paralyse worms, 
because they are older and less well studied than the highly effective 
benzimidazole drugs, mebendazole and albendazole, which superseded 
levamisole and pyrantel in 1975 and 1980 respectively (Horton, 2003b).  In 
general the benzimidazoles are less effective against T.trichiura than against 
A.lumbricoides and the hookworms, and are less effective against hookworm 
than against A.lumbricoides.   
Insert Table 7 here 
 There also seem to be differences in the efficacy of the two 
benzimidazole anthelmintics, even though they are chemically similar.  Table 
8 shows data from a large study in Zanzibar of treating intestinal nematode 
infections with albendazole or mebendazole which revealed statistically 
significant differences in the efficacy of treating hookworm (Albonico et al., 
1994).   
 A reason for the lower efficacy of drugs to treat hookworm compared 
with A.lumbricoides may be because hookworms are usually physically 
attached to the gut and may be better able to resist the transient effects of 
anthelmintic drugs than A.lumbricoides which can only maintain their position 
in the gut by actively swimming against the intestinal flow.   
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 The reason for the lower efficacy of T.trichiura compared with both 
A.lumbricoides and the hookworms may be because they live in the large 
intestine, where anthelmintic drugs may be more dilute than in the small 
intestine.  Adult T.trichiura are also typically embedded in the gut wall by their  
whip-like anterior end, which may provide an anchor so that they, like 
hookworms, can withstand any transitory effects of anthelmintic drugs.  A 
study in Bangladesh showed that, in order to achieve a cure rate for 
T.trichiura of 80%, 400 mg albendazole had to be given daily for three 
consecutive days (Hall and Nahar, 1994).  
 There is also evidence that there may be a lower cure rate for 
T.trichiura in Asia than in Africa: an analysis of trials of albendazole showed a 
median cure rate of 33% in Asia compared with 61% in Africa (Bennett, 2000),   
 There is obvious concern that repeated mass treatment could lead to 
the development of drug resistance, something that has been shown to 
develop as a result of repeated treatment (Albonico et al., 2003).   There are 
substantial lessons to be learned from veterinary medicine in which the same 
anthelmintic drugs have been used for many years and far more intensively 
than in humans (Coles, 1995).  Strategies to avoid or delay the development 
of drug resistance should be applied (WHO, 2002a), such as alternating drugs 
with different modes of action, and the efficacy of treatment should be 
assessed periodically at sentinel sites during mass treatment programmes, 
the interval to depend on the frequency of treatment (WHO, 2002a).  
  The main limitation to alternating treatments has been the lack of 
effective alternatives to the albendazole and mebendazole, as single dose 
treatments.  One possibility is a combination of pyrantel and oxantel which 
has been shown to be quite effective in comparison with mebendazole 
(Albonico et al., 2002, Rim et al., 1975), but this mixture is not widely 
available.  A combination of albendazole and ivermectin has been tested as a 
treatment for lymphatic filariasis (Beach et al., 1999b, Belizario et al., 2003, 
Horton et al., 2000) and has effects on the major species of soil-transmitted 
helminths as well.  The advantage of giving two drugs in combination is that 
the chance of genes that confer resistance to both treatments at the same 
time is greatly reduced.  
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 A relatively new drug called nitazoxanide has been shown to be an 
effective treatment for all major species of intestinal nematode worms as well 
as Hymenolepis spp (Juan et al., 2002, Romero Cabello et al., 1997).  But the 
drug currently has to be given twice a day for three days whereas the others 
are single dose treatments, which ensures compliance in mass treatment 
campaigns.  The major advantage of nitazoxanide is that it is an effective 
treatment for intestinal protozoa, including Giardia duodenalis and 
Cryptosporidium spp, as well as anaerobic bacteria such as Helicobacter 
pylori and Clostridium difficile (Bobak, 2006, Megraud et al., 1998).  Such a 
drug could have a significant impact on growth and nutritional status, as 
studies of giving metronidazole, another broad-spectrum antibacterial and 
anti-protozoal drug have suggested (Gupta and Urrutia, 1982, Khin Maung et 
al., 1990). 
 The differences in the efficacy of treatments for intestinal nematode 
worms will therefore depend on the drug, the dose of drug, the species of 
worm, and the strain of the worm perhaps, which will all have consequences 
for the impact of treatment on nutritional status and growth.  In some studies 
included in this review a single treatment was given, in others, repeated 
treatment was given using the same drug.  And in one study included in the 
review, two different drugs were given: pyrantel pamoate at the first treatment 
and then mebendazole for subsequent bi-monthly treatments (Northrop-
Clewes et al., 2001).   
 The situation is further complicated if anthelmintic drugs to treat other 
types of worms are given, such as praziquantel or metrifonate to treat 
infections with Schistosoma species.  This is a genus of blood flukes found in 
Africa, the Middle East, Asia and South America, often concurrently with 
infections with intestinal nematode worms.  Schistosoma haematobium 
causes bleeding into the urinary bladder as a result of the passage of the 
sharp-spined eggs through tissues, while the passage of the eggs of 
Schistosoma mansoni and Schistosoma japonicum through the gut wall also 
causes internal bleeding.  Studies of the impact of treatment in areas in which 
schistosomes occur tend to give a drug to treat these infections, as well as a 
drug to treat intestinal nematode worms (Beasley et al., 1999, Friis et al., 
2003).  As well as treating schistosomes, the drug metrifonate is also an 
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effective treatment for hookworm (Kurz et al., 1986), which complicates 
studies and measuring outcomes due to treatment. 
 Finally, if any study is to assess the impact of treating intestinal worms  
alone, then additional treatments cannot be given unless a factorial design is 
used and an untreated control group is provided.  One study of the effect of 
treating worms with mebendazole also gave all subjects metronidazole as 
well, a broad-spectrum anti-bacterial drug that also treats infections with 
intestinal protozoa (Marinho et al., 1991).  This meant that the effect of 
mebendazole could not be separated from the effect of metronidazole.  In 
other studies supplements of micronutrients or food were also provided which 
also may have had independent effects on nutritional status and growth so 
making it impossible to estimate the impact of deworming alone (Latham et 
al., 1990a, Lind et al., 2004, Majumdar et al., 2003). 
 
3.3 Intervals between treatments 
In an infected human population the death rate of worms tends to a reach a 
balance with the rate at worms are acquired, so an equilibrium develops.  The 
effect of mass treatment is to cure a proportion of people, which reduces the 
prevalence of infection, and treatment expels a proportion of the total worm 
population, which reduces the mean worm burden.  But, as there is no fully 
protective immunity to worms, reinfection can occur immediately, especially as 
infective eggs can survive in the environment for months in suitable 
conditions.  The rate of reinfection is strongly related to the prior prevalence 
and mean worm burden, as well as to local sanitation, which influences the 
number of infective stages in the environment.  Studies of reinfection after 
treatment and mathematical models that simulate treatment and reinfection 
have shown that the prevalence of infection can rebound within a few months 
after treatment, but that the worm burden takes considerably longer to reach 
the pre-existing number (Hall et al., 1992).  This means that the prevalence 
may show only a small difference between rounds of treatment, but the mean 
worm burden may decline.   
 Figure 10 shows data on the prevalence of infection with 
A.lumbricoides among 445 school-age children in Bangladesh at the first 
treatment and after two more rounds of treatment, each six months apart.  
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The dotted line shows the trend which, when extrapolated, suggests only a 
small decline over two future rounds of treatment.  Figure 10 also shows the 
mean worm burden at each round of treatment, which declines by almost 60% 
between the first and third treatment.  If the linear decline was extrapolated it 
would lead to a substantial reduction in mean worm burden after five rounds 
of treatment.  The relatively slow decline in worm burden achieved in the 
study in Bangladesh suggests that treatment would actually be best given 
every 3 – 4 months or 3 – 4 times a year rather than twice a year.  
Insert Figure 10 here 
 Figure 10 makes the point that the interval between treatments will 
influence the average intensity of reinfection that occurs, assuming a high 
efficacy, especially in the absence of any measures to prevent exposure to 
infectious stages in the environment or if only a proportion of the population is 
treated.  Ideally the intervals between treatment should prevent the 
prevalence rising above 50%, the threshold at which the probability of 
moderate to heavy infections begins to increase exponentially (see Figure 3). 
 The conclusion is that the frequency of treatment is therefore likely to 
affect the impact of treatment, and the aim should be to prevent moderate to 
large worm burdens from being reacquired.  The consequence for this review 
is that it is difficult to compare studies of different numbers of treatments given 
over different periods.  Nevertheless it can be useful to standardise gains in 
weight or any other parameter per unit of time, such as per year (Alderman et 
al., 2006).  But, if reinfection is rapid, then two or even three treatments a year 
may have a greater impact than one, assuming that worms are the only 
constraint on growth.   
 
3.4 Duration of follow up 
It follows from the discussion in the previous section that, as well as the 
number of treatments given, the duration of follow up after treatment will affect 
the magnitude of any difference between a treated and an untreated control 
group, and therefore its statistical significance.  This is illustrated in Figure 11 
which shows hypothetical data on the weight of two cohorts of undernourished 
children, 300 treated and 300 untreated, over a period of three years during 
which the treated group were kept almost free of worms.  The children were 
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five years old at the start of the study and were underweight, with an average 
body weight that was 2 standard deviations below the NCHS median.  If the 
periodic treatment of worms led to an extra gain in weight of 0.5 kg a year, or 
3.5% of the initial mean weight, then it can be seen from the confidence 
intervals around the means in Figure 11 that it is not until the third year that a 
statistically significant difference between groups is achieved 
Insert Figure 11 here 
 The duration of follow up is important because, as Section 2.4 has 
shown, a relatively small proportion of infected subjects will benefit from  
treatment so it is likely to take some time before the effects of repeated 
treatment are detectable in comparison with an untreated infected group.  
Some studies have attempted to measure a difference between groups in 
weight gain or growth over a very short period, such as 3 or 7 weeks after 
treatment (Hadju et al., 1996).  Even though there was a statistically 
significant difference between study groups in such studies, it is too short a 
period to warrant inclusion in the review.  Another study attempted to measure 
a change in haemoglobin and iron status over a period of 10 days after 
treatment (Karyadi et al., 1996), which is also a very short time in which to 
expect an improvement.   
 
3.5 Outcomes measured and the need for controls 
The primary outcomes usually measured during studies of the effect of 
anthelmintic treatment are changes in body weight, height, mid upper arm 
circumference and skinfold thickness.  A change in haemoglobin 
concentration may also be expected if hookworm or T.trichiura occur.  
Measuring vitamin A status is hard to do as the concentration of retinol in 
serum is usually sustained from liver stores, so some sort of dose response 
test is usually used.  Secondary outcome measures are anthropometric 
indices such as height-for-age and weight-for-age, which both require age to 
be known, ideally to within a month, and weight-for-height or body mass 
index.  Indices of weight-for-height can only be calculated for girls younger 
than 10 years and boys younger than 11.5 years if the National Centre for 
Health Statistics reference values are used (WHO, 1983) which may limit their  
application in studies of school-age children.  Z-scores of anthropometric 
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indices are useful when controlling for the initial nutritional status of subjects 
based on the assumption that, when there is a large initial deficit, the impact 
of treatment is likely to be greater than if there is a small initial growth deficit.  
A change in z-score can also help to give a perspective to the magnitude and 
nutritional significance of an improvement.   
 It cannot be assumed that a gain in body weight is due totally to an 
increase in lean body mass, because some increase could result from the 
deposition of fat in adipose tissue.  Although there are now available weighing 
scales that can estimate the percentage body fat by applying standard 
equations to measurements of electrical impedance, they cannot usually be 
applied to young children, and may not apply to undernourished children in a 
developing country either.   
 Measurements of mid-upper arm circumference and triceps skinfold 
thickness tend to be under-used in studies of  child growth after deworming.  
Their value lies in the ability to estimate the surface area of sub-cutaneous fat 
and muscle in the arm, assuming a standard area of bone (Gibson, 1990)  
which could indicate both growth in lean tissue and the deposition of fat 
reserves.   
 A statistically significant weight gain can be achieved over a relatively 
short period, especially if food is available ad libitum, while a gain in height 
can take relatively longer.  A period of about 12 weeks seems to be about the 
minimum period of follow up.  A study of vitamin A and iron given to 
Tanzanian children after treatment with albendazole and praziquantel showed 
statistically significant extra gains in weight and height after 3 months of 
supplementation (Mwanri et al., 2000).   
 Studies of the effects of treating worms that cause blood loss require 
controls because the haemoglobin concentration can fluctuate naturally.  
Studies of giving iron supplements to school-age children after deworming 
have shown statistical significance only because the mean value of the control 
group may go down in comparison with the treated children whose 
haemoglobin was sustained by the iron (Hall et al., 2002, Roschnik et al., 
2004, Aguayo, 2000).  Natural fluctuations in haemoglobin may occur as a 
result of changes in the diet and diseases such as malaria, both or which may 
be seasonal.   
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3.6  Initial nutritional status 
The impact of treatment on any indicator of nutritional status is likely to be 
related to the prior degree of undernutrition or deficiency, thus the margin for 
potential improvement.  This was not the case in a study in South Africa of the 
effect of anthelmintic treatment and micronutrient fortified biscuits (Jinabhai et 
al., 2001b).  One of the outcome measures was anthropometric status, but at 
the start of the study only 7.3% of children were stunted and 0.8% were 
underweight (Jinabhai et al., 2001b), not a large margin for improvement.  
 It may seem obvious, but it is also important that treatment and control 
groups should be similar before any treatment is given.  A study of the impact 
of treatment with mebendazole given to young children as a part of an 
evaluation of the Integrated Management of Childhood Illness in western 
Kenya reported statistically significant differences in gains in weight, height 
and weight-for-age when infected and treated children were compared with 
infected and untreated controls (Garg et al., 2002).  But in this study the 
treated children were significantly more undernourished than the control 
group: the z-score of weight-for-height of the group given the placebo was 
much greater than the treated children (Treatment -0.89 vs  Control -0.19, P < 
0.001) and there was a statistically significant difference in their initial weight-
for-age as well (-1.43 vs  -1.01, P < 0.001) (Garg et al., 2002).  If the infected 
and treated children gained more weight it could easily have been because 
they started from a lower initial nutritional status and had a greater potential to 
achieve more catch-up growth.  Both the treatment and control groups need to 
be similar if the impact of treatment on growth or most nutritional variables is 
to be compared reliably. 
 
3.7 Age of subjects 
The age of subjects will influence the measurement of the impact of 
anthelmintic treatment.  This is because growth is not linear during childhood 
and shows two spurts, the first during the first two years of life, and the 
second during adolescence.  Although the prevalence and intensity of worm 
infections tends not to be as high during the first two years of life as during the 
school-age years, the potential impact of worms early in life is greater, mainly 
because of the relative size of worms to their hosts, and the relative 
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magnitude of any extra weight gain achieved after treatment.  An extra weight 
gain of 500 g over a year by a 5 year old girl whose weight is 2 S.D. below the 
mean is 3.6% of initial weight; for a 10 year old it is 2.3% and for a 15 year old 
it is 1.3%.  Such an extra weight gain is of decreasing biological significance, 
unless it can be sustained each year, and will require a larger sample size to 
detect in the older age groups. 
 
3.8 Remedial therapy after treatment 
An implicit assumption of many randomised trials of anthelmintic treatment 
seems to be that removing worms will automatically lead to improvements in 
growth and nutritional status.  This may happen, but only if the diet is 
adequate (Hall, 2007).  If worms have impaired growth, the haemoglobin 
concentration or micronutrient status, their effects are most likely to have been 
due to the mechanisms outlined in Section 1.3 which are worth repeating 
here: by feeding on the host’s food, secretions, tissues and blood; by causing 
maldigestion or malabsorption; by effects on appetite and food intake; and by 
causing responses to infection that consume or divert resources 
unnecessarily.   The losses or deficits caused by worms cannot be rectified or 
remedied simply by removing the worms alone, although halting any 
pathological processes is an important first step.  After worms have been 
killed the need is for remedial treatment of the underlying nutritional deficits by 
providing energy, protein and micronutrients, so that catch-up growth can be 
achieved.  This is illustrated in Figure 12 and discussed in some detail in 
Section 6.2.   
Ideally, children should be protected from moderate to heavy infections 
throughout their childhood by repeated treatment to keep worm burdens low, 
by primary measures such as sanitation to prevent faeces containing worm 
eggs from getting into the environment, and by secondary measures to 
prevent exposure to worm eggs, such personal hygiene. 
Insert Figure 12 here 
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3.9 Summary   
There are a number of factors related to anthelmintic drugs and study design 
that need to be considered when either designing studies or evaluating 
papers that report studies. 
• Different drugs give a different cure rate and egg reduction rate for 
each species of intestinal nematode; 
• All anthelmintics are highly effective against A.lumbricoides; 
• Albendazole 400 mg and mebendazole 500 mg are the best treatments 
available for hookworms and T.trichiura; 
• At these dosages albendazole is more effective than mebendazole 
against hookworm infections, but both achieve egg reduction rates of 
55 – 95%; 
• Neither albendazole nor mebendazole given as a single dose cures 
many infections with T.trichiura,  but such treatment can reduce egg 
counts by 50% 
• Albendazole and mebendazole may be a less effective treatment for 
T.trichiura in Asia than in Africa 
• Three daily doses of albendazole or mebendazole may be needed to 
achieve high cure rates for T.trichiura. 
• Reinfection with worms can occur immediately after treatment, so 
treatment needs to be given periodically.   
• The interval between treatments may influence the impact on growth 
and nutritional status. 
• The subjects for study should be malnourished as well as infected. 
• As a minority of children (ranging from 10 – 40%) have moderate to 
heavy infections, not all will benefit to the same degree from treatment, 
and the impact on the average will of any outcome measure may be 
diluted. 
• These factors should be taken into account so that the period of follow 
up after treatment should be sufficient to be able to detect a statistically 
significant effect. 
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• It cannot be expected that nutritional status will improve and show 
catch-up if the diet of subjects is inadequate to meet the extra 
requirements. 
 
4. Aims and methods of the meta-analysis 
The aim of the review was to identify studies that had measured the effect of 
anthelmintic treatment given for infections with A.lumbricoides, T.trichiura and 
both species of hookworm on children’s growth and weight gain, or on 
haemoglobin concentration.   
 
4.1 Search terms 
Table 9 shows the terms used in combination to search Medline.  The search 
was limited to papers on humans in the following groups: infant, preschool, 
child and adolescent.  Only papers in English were located. In addition, the 
reference list of each paper identified was scanned for other papers, so too 
was the Cochrane Review of 2000 (Dickson R, 2005, Dickson et al., 2000a, 
Dickson et al., 2005) and the book by Stephenson (1987) Impact of helminth 
infections on human nutrition (Stephenson, 1987). One unpublished paper 
known to the principal author, who was a co-investigator, was included 
(Partnership for Child Development, 2001).  
 All papers identified were summarised under the following headings: 
• Design.  A summary of the study design, including whether placebo 
controlled and blinded or not.  
• Follow-up.  The period children were studied after treatment, or the 
difference in time between the initial, interim and final measurements. 
• Location.  The region and country where the study was done. 
• Age range. 
• Infection prevalence at baseline.  The prevalence of each species of 
worm recorded. 
• Treatments.  The drugs used and the doses given. 
• Sample size.  The number of subjects studied in each group. 
• Outcomes.  The principal outcome measures and any derived indices. 
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• Findings.  A summary of the major findings with standard deviations 
and the statistical significance of any differences between groups. 
• Notes.  A summary of the prevalence of each intestinal nematode 
infection; a summary of the effect of treatment of worms; a summary of 
the degree of undernutrition estimated as z-scores, the mean 
haemoglobin concentration or the prevalence of anaemia; and short 
notes on other major or different features of the study. 
• In Cochrane review of 2000 (recorded as Yes or No):  
 Dickson R, Awasthi S, Demellweek C, Williamson P.  Anthelmintic 
drugs for treating worms in children: effects on growth and cognitive 
performance (Review).  Cochrane Database of Systematic Reviews, 2000, 
Issue 2.  DOI: 10.1002/14651858.CD000371. 
• Included in meta-analysis.  Either Yes, or the reason the study was 
excluded is given. 
 
4.2  Inclusion criteria 
Papers were included in the analysis if the following criteria were met: 
• Studies of treating children and adolescents (aged 1 – 19 years) for 
intestinal nematode worm infections with albendazole, levamisole, 
mebendazole, piperazine or pyrantel (pamoate or embonate). 
• An experimental group given the anthelmintic alone. 
• An untreated control group. 
• Random allocation to treatment and control groups. 
• An initial prevalence of infection in children in the study locality with 
any species of intestinal nematode worm of ≥ 50%, the threshold used 
by the WHO to classify a “high risk” community (WHO, 2006).  
• A duration of follow-up of at least 12 weeks for all outcomes except the 
modified relative dose response test to an oral dose of retinol 
(Tanumihardjo et al., 1996a). 
• Outcomes measured included at least one primary outcome variable 
among weight, height, mid upper arm circumference, skinfold 
thickness, haemoglobin concentration, and a measure of serum retinol; 
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or secondary outcomes based on weight-for-age, height-for-age or 
weight-for-height such as z-scores or percentages of the median. 
• Data given as a mean with standard deviation and sample size, or 
enough data to calculate the standard deviation.  
 Data from the study of (Koroma et al., 1996) were entered separately 
for urban and rural children. 
 
4.3 Exclusion criteria  
Papers were excluded from the meta-analysis for one or more of the following 
reasons (the references cited are examples, and is not a comprehensive list): 
• Data on an outcome measurement not presented in a form that could 
be used  e.g. change in percentage weight for height (Hadidjaja et al., 
1998), difference in percentage improved (Kloetzel et al., 1982), 
change in percentage with anthropometric indices less than -2 z-scores 
(Lai et al., 1995), weight gain presented as a graph (Sur et al., 2005), 
no data given for stated outcome measures for treated children (Olds 
et al., 1999); or data are unique so could not be combined with other 
studies (Tanumihardjo et al., 1996b). 
• No standard deviations of outcome measures given (Beach et al., 
1999a, Fox et al., 2005, Greenberg et al., 1981, Michaelsen, 1985, 
Rousham and Mascie-Taylor, 1994, Willett et al., 1979) so not 
amenable to meta-analysis using Review Manager 4.2 software. 
• The initial prevalence of worms was less than the “high risk” threshold 
of 50% (Garg et al., 2002, Awasthi et al., 2000, Awasthi and Pande, 
2001, Donnen et al., 1998, Freij et al., 1979); 
• Inadequate control group or method of allocation e.g. infected subjects 
treated and compared with subjects who were lightly infected or 
uninfected (Mahendra Raj and Naing, 1998, Mahendra Raj, 1998, 
Bhargava et al., 2003, Callender et al., 1994); a sample size of two, 
one village where children were treated and another control village 
where they were not (Fernando et al., 1983); or no untreated controls 
(Forrester et al., 1998). 
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• Treatment given for other conditions in addition to treatment for 
intestinal nematode worms e.g. metrifonate, which treats hookworm as 
well as Schistosoma spp (Stephenson et al., 1989a, Stephenson et al., 
1989b, Stephenson et al., 1985); praziquantel to treat Schistosoma spp 
combined with a drug to treat intestinal nematode worms (Beasley et 
al., 1999, Kruger et al., 1996, Jalal et al., 1998, Jinabhai et al., 2001a); 
or food or micronutrient supplements given in addition to anthelmintic 
treatment (Cerf et al., 1981, Marinho et al., 1991, Jinabhai et al., 
2001b, Mwaniki et al., 2002, Kruger et al., 1996, Palupi et al., 1997) 
• Short period of follow up e.g. 3 and 7 weeks (Hadju et al., 1996), 10 
days (Karyadi et al., 1996). 
 
4.4 Meta-analysis 
Data from suitable papers were extracted and entered manually into RevMan 
version 4.2.8 for Windows.b    
 Statistical comparisons were made between subjects treated with an 
anthelmintic drug and untreated controls for the outcomes listed in Table 13.  
For some studies the standard deviations had to be calculated from 95% 
confidence intervals and the sample size.  For studies in which the mean and 
standard deviations of values before and after were given, the difference 
between mean values was used in the analysis with a pooled estimate of the 
standard deviation. 
 The weighted mean difference between treatment and control groups 
was calculated with 95% confidence intervals in RevMan 4.2 software 
(RevMan, 2003) for each variable using a fixed effects model.  Studies were 
disaggregated into sub-categories by treatment except that studies in which 
mebendazole and albendazole were given were combined, as the two drugs 
are chemically similar and have the same mode of action.  
 
 
                                            
b
   Downloaded from http://www.cc-ims.net/RevMan 
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5. Results of the meta-analysis  
A total of 58 published papers were found, summaries of which can be found 
in the Appendix.  They were not all unique studies as some data were 
reported in more than one paper.  A total of 40 papers were not included in 
the analysis either because they met exclusion criteria or did not meet 
inclusion criteria; this left 18 studies for analysis.  One additional unpublished 
study, a randomised cluster trial of albendazole in Vietnamese schoolchildren, 
was included, (Partnership for Child Development, 2001) increasing the 
sample to 19 papers, as follows:  
Adams et al. (1994). Physical activity and growth of Kenyan school children 
with hookworm, Trichuris trichiura and Ascaris lumbricoides infections 
are improved after treatment with albendazole. Journal of Nutrition 124: 
1199 – 1206. (Adams et al., 1994) 
Alderman et al. (2006)  Effect on weight gain of routinely giving albendazole to 
preschool children during child health days in Uganda: cluster 
randomized controlled trial. British Medical Journal 333: 122 -24. 
(Alderman et al., 2006) 
Dossa et al. (2001). Impact of iron supplementation and deworming on growth 
performance in preschool Beninese children.  European Journal of 
Clinical Nutrition 55: 223 – 228. (Dossa et al., 2001) 
Gupta et al. (1982). Effect of periodic antiAscaris and antiGiardia treatment on 
nutritional status of preschool children.  American Journal of Clinical 
Nutrition 36: 79 – 86. (Gupta and Urrutia, 1982) 
Koroma et al. (1996). Effects of albendazole on growth of primary school 
children and the prevalence and intensity of soil-transmitted helminths 
in Sierra Leone.  Journal of Topical Pediatrics 42: 371 – 372.(Koroma 
et al., 1996)     
Northrop-Clewes et al. (2001). Anthelmintic treatment of rural Bangladeshi 
children: effect on host physiology, growth, and biochemical status. 
American Journal of Clinical Nutrition 73: 53–60.(Northrop-Clewes et 
al., 2001) 
Partnership for Child Development (2002, unpublished). A randomised cluster 
trial of six-monthly deworming and its effects on the growth and 
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educational achievements of Vietnamese school children.  (Partnership 
for Child Development, 2001) 
Sarkar et al. (2002).  Effect of deworming on nutritional status of Ascaris 
infested slum children of Dhaka, Bangladesh. Indian Pediatrics 39: 
1021 – 1026. (Sarker et al., 2002) 
Simeon et al. (1995).  Treatment of Trichuris trichiura  infections improves 
growth, spelling scores and school attendance in some children. 
Journal of Nutrition 125: 1875 – 1883, (Simeon et al., 1995) 
Stephenson et al. (1989c). Treatment with a single dose of albendazole 
improves growth of Kenyan schoolchildren with hookworm, Trichuris 
trichiura and Ascaris lumbricoides infections.  American Journal of 
Tropical Medicine and Hygiene 41: 78 – 87.(Stephenson et al., 1989c) 
Stephenson et al. (1993a).  Weight gain of Kenyan school children infected 
with hookworm, Trichuris trichiura and Ascaris lumbricoides is 
improved following once- or twice-yearly treatment with albendazole.  
Journal of Nutrition 123: 656 – 665. (Stephenson et al., 1993b) 
Stephenson et al. (1993b). Physical fitness, growth and appetite of Kenyan 
school boys with hookworm, Trichuris trichiura and Ascaris 
lumbricoides infections are improved four months after a single dose of 
albendazole. Journal of Nutrition 123: 1036 – 1046. (Stephenson et al., 
1993a) 
Stoltzfus et al. (1997).  School-based deworming program yields small 
improvement in growth of Zanzibari school children after one year.  
Journal of Nutrition 127: 2187 – 2193. (Stoltzfus et al., 1997) 
Stoltzfus et al. (1998).  Effects of the Zanzibar school-based deworming 
program on iron status of children. American Journal of Clinical 
Nutrition 127: 179 -186. (Stoltzfus et al., 1998) 
Stoltzfus et al. (2004).  Low dose daily iron supplementation improves iron 
status and appetite but not anemia, whereas quarterly anthelmintic 
treatment improves growth, appetite and anemia in Zanzibari preschool 
children. Journal of Nutrition 134: 348 – 356. (Stoltzfus et al., 2004) 
Tanumihardjo et al. (1996)  Vitamin A status of Indonesian children infected 
with Ascaris lumbricoides after dosing with vitamin A supplements and 
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albendazole. Journal  of Nutrition 126: 451 – 457.(Tanumihardjo et al., 
1996b) 
Tanumihardjo et al. (2004). Vitamin A status and hemoglobin concentrations 
are improved in Indonesian children with vitamin A and deworming 
treatments.  European Journal of Clinical Nutrition 58: 1223 – 1230. 
(Tanumihardjo and Permaesih, 2004) 
Thein-Hlaing et al. (1991).  A controlled chemotherapeutic intervention trial on 
the relationship between Ascaris lumbricoides infection and 
malnutrition in children. Transactions of the Royal Society of Tropical 
Medicine and Hygiene 85: 523 – 528. (Thein-Hlaing et al., 1991) 
Watkins et al. (1996).  Effect of removing Ascaris on the growth of 
Guatemalan schoolchildren. Pediatrics 97: 871 -876.(Watkins and 
Pollitt, 1996) 
 Table 10 shows a summary of the key features of the 19 studies.  The 
studies could not be disaggregated by age into pre-school (1 – 5 y) and 
school age (6 – 15 y) because several had overlapping age ranges, 
particularly the largest study, undertaken by Alderman et al. (Alderman et al., 
2006) in Uganda. 
Insert Table 10 here 
 
5.1 Geographic origin of studies 
Table 11 shows the countries represented in the papers found and used in 
this review.  Of all 58 papers found, nearly 50% reported data from Africa.   Of 
the 19 papers used in the analysis, a little more than 50% reported data from 
Africa. 
Insert Table 11 here 
 
5.2 Estimates of effects  
Table 12 presents summary data on the impact of treatment on 12 variables 
for all studies in which intestinal worms were treated with any effective 
anthelmintic.  The drugs used were albendazole and mebendazole, 
levamisole, piperazine or pyrantel pamoate.  There were statistically 
significant differences for most variables related to growth; neither of the 
outcomes for micronutrients were statistically significant.   
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Insert Table 12 here 
 Table 13 presents summary data on the impact of treatment on 12 
variables for all studies in which intestinal worms were treated with 
albendazole or mebendazole only, as these drugs are now the most widely 
used and most broadly effective anthelmintics.   
Insert Table 13 here 
 
5.3 The figures and how to interpret them 
Figures 13 to 24 show the mean differences between treated and control 
groups for each study grouped vertically by the drugs used.  The mean is 
shown as a box around the vertical line of zero difference, with 95% 
confidence intervals (95% CI) shown as bars.  The diamonds represent the 
weighted mean difference (WMD) between the treated and control groups for 
each treatment group and in total.  The percentage weight given to each study 
is shown and the numerical value of the estimated difference with 95% CI.  It 
should be noted that the scale in all but figures except for Fig 22, 25 and 25 is 
from –4 (favours control) to 4 (favours treatment).   
 
5.4 Sources of error or bias 
The decision to exclude studies in which the initial prevalence of infection is 
< 50% is somewhat arbitrary, but is based on the WHO threshold which 
classifies them as “low risk” communities (WHO, 2006).  Ideally all children 
taking part in studies of anthelmintic treatment would be infected with at least 
one species of worm, just as any drug trial would be conducted only on 
infected individuals.  But most trials of the impact of anthelmintics on child 
growth tend to study groups of children rather than infected subjects only, so 
tend to be trials of effectiveness rather than efficacy.  This type of study is 
driven also because of ethical problems with having infected but untreated 
children as controls, so studies tend to be done in communities in which the 
prevalence is known, and whether individual subjects are infected or usually 
unknown.  Applying a threshold prevalence of 50% or more means that a half 
of all subjects or fewer will not benefit from anthelmintic treatment, and their 
inclusion in the study sample will to some degree dilute the impact of 
treatment on the infected majority.  The threshold prevalence of 50% does not 
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serve to maximise the impact of treatment, a prevalence of 100% is needed to 
do that, but a prevalence higher than 50% serves to reduce the effect of 
uninfected subjects.  This means that the conclusions of the meta-analysis 
can only be applied to circumstances in which the prevalence is more 50% 
and excludes what the WHO calls “low risk” communities, in which the 
prevalence of infection with any species of worm lies between 20 – 49% 
(WHO, 2006). 
 About a half of all papers found and used in the analysis reported data 
from Africa.   All of the papers reporting African data were from sub-Saharan 
Africa, reflecting concern for the effects of worms in African children.   
In many parts of sub-Saharan Africa children are concurrently infected 
with species of Schistosoma, which may cause loss of appetite, internal 
bleeding, and tissue damage and inflammation due to reactions to the eggs of 
worms when they become lodged in tissues.  Studies were excluded from this 
analysis in which subjects were also treated with praziquantel or metrifonate, 
the drugs most commonly used to treat Schistosoma spp,  as this would over-
estimate the effect of treating intestinal nematodes.  This could, however, 
have led to a bias against studies from sub-Saharan Africa.  But this did not 
seem to be the case, as a larger proportion of all papers from Africa were 
included in the final analysis than in Africa, Asia or the Indian sub-continent.  
Of the papers found and the papers used, the proportion from Africa was 
similar in both categories (28/59 or 47% and 11/24 or 46%). 
 
Insert Figures 13 to 24 here 
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6. Discussion 
This meta-analysis indicates that if the prevalence of intestinal nematodes is 
50% or more then giving anthelmintic drugs leads to significant extra gains in 
weight, height, mid upper arm circumference and skinfold thickness in 
comparison with untreated controls.  Table 12 shows the weighted average 
changes recorded in the studies found.  The gains in weight and height also 
led to improvements in indices of anthropometric status in studies in which 
only these outcomes were reported. There was no evidence of a significant 
effect of treating intestinal nematode infections on haemoglobin concentration.  
Only two studies, both by the same author in Indonesia, were reported of the 
dehydroretinol to retinol ratio, and found no difference between treated and 
control groups (Tanumihardjo and Permaesih, 2004, Tanumihardjo et al., 
1996b).  
 
6.1 Magnitude of effects 
It is not possible to say anything conclusive about the absolute magnitude of 
any effects of giving treatment, for a number of reasons.  The studies 
summarised were different in terms of:  
• the species and mixture of species of worms; 
• the distribution of worms between hosts; 
• the drug and dose used, leading to variability in the efficacy of each 
treatment; 
• the number of treatments given and intervals between them; 
• the initial degree of undernutrition, the age and current health of 
subjects; 
• and the period of follow-up after treatment, or the gap between the 
initial and final measurements. 
 The magnitude of the extra increases shown in Figures 14  – 25 are not 
standardised as gains per unit time, which would have enabled them to be 
better compared, and would have put any improvement into some sort of 
perspective.  A extra gain in weight of 0.2 kg in four months is much bigger 
and more significant in terms of growth than a extra gain of 0.2 kg over a year.  
Any gain per unit time will also be influenced by the frequency of treatment, 
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thereby keeping worm burdens down, perhaps.  This was indicated in the 
study in Uganda: children who were dewormed at least every six months 
gained an extra 10% in weight compared with the 5% extra by children who 
were treated only annually (Alderman et al., 2006).  However this could have 
been confounded by the fact that other health services were delivered at the 
Parish Health Fairs to children who came more often, or perhaps the regular 
attendance of children at Health Fairs also reflected better care at home. 
 If the magnitude of any gain is related to the initial degree of  
undernutrition, then it might be better to standardise the gain per unit time as 
a proportion of the initial value, though this may be statistically difficult to do.  
This could be important for the haemoglobin concentration.  For example, an 
increase of 10 g/L when the initial average was 90g/L (11%) is more 
significant than an increase of 10 g/L when the initial average was 110 g/L 
(9%).    
 Nothing can be said about whether any particular drug is more effective 
than another at bringing about an improvement in a nutritional outcome, 
although egg reduction rate is likely to be a good indicator of this.  The 
benzimidazole drugs are currently the most efficacious treatments available 
for treating intestinal nematode worms.   Albendazole was the most commonly 
used drug (Table 10), and is effective to differing degrees against the three 
main species of worms, as Table 7 shows.  Mebendazole has a similar 
efficacy but was given less often, probably because it used to be given as a 
dose of 100 mg a day for 3 days rather than as a single dose of 500 mg, as it 
is now used.  A single dose of an effective drug is a crucially important 
attribute for a helminth disease control programme.  However neither 
albendazole nor mebendazole are highly effective against T.trichiura (Bennett, 
2000), and a failure to achieve a good egg reduction rate could contribute to a 
smaller impact of treatment than could be achieved by giving multiple doses. 
 
6.2 Treatment alone is not enough 
Whatever extra gains in nutritional or anthropometric outcomes are achieved 
after treatment with an anthelmintic drug, they do not occur solely as a result 
of that treatment.  Catch-up growth, for example, requires extra nutrients and 
energy, and if they are not available after treatment then growth rates are 
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likely to remain unchanged.  Alternatively a statistically significant difference 
between a treatment and control group could occur during a study because an 
untreated control group remain persistently diseased as a result of their 
infections, and thus gain less weight than the treated group.   
 The lack of extra food to meet the needs for growth could explain the 
lack of impact of deworming in many studies, such as the large cluster trial in 
Viet Nam (Partnership for Child Development, 2001).  The expulsion of worms 
from the gut may remove a constraint that acts through effects on appetite 
and food intake, digestion and absorption, or because of the diversion of 
nutrients in response to infection.  But to achieve the maximum growth rate 
after treatment, energy, protein and micronutrients need to be provided to 
children, preferably ad libitum .  Most studies did not give food supplements 
after treatment, but one that did showed an improved appetite measured as 
food intake as well as improved growth (Stephenson et al., 1993a).  
 Catch-up growth is possible (Golden, 1994) especially if the deficits 
occur early in childhood and are treated adequately.  Studies of children 
treated for Trichuris dysentery syndrome, admittedly an acute disease, have 
shown an average gain of nearly 11 cm in height and 4 kg in weight a year, 
which was more than 2 S.D. above the expected gain in height and weight of 
British children of the same age (Cooper et al., 1995).  Some of the 5-year-old 
children studied showed an annual growth velocity of nearly 20 cm a year and 
a weight gain of 10 kg.   
 To achieve such catch-up growth children need to be fed ad libitum, not 
just with energy and protein, but also with micronutrients, so that no nutrient is 
limiting and the maximum possible growth is achieved (Hall, 2007).  If studies 
of deworming have failed to show an impact on growth or weight gain it could 
be because children were not getting enough of the food and micronutrients 
they needed to achieve catch-up growth.  And the studies that have shown a 
statistically significant impact of treatment may have underestimated the 
potential effect if children did not have an ideal and balanced diet given ad 
libitum.  No published studies have been found of randomised controlled trials 
of deworming with or without any form of remedial feeding given ad libitum; 
most studies have only given supplementary food or supplementary 
micronutrients.   
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 A problem with giving food supplements is that there can be 
substitution, in which people eat less food at home after being fed at school or 
work (Wolgemuth et al., 1982).  Or supplementary food may benefit the better 
off most: a study of a school nutrition programme in Viet Nam found that 
better nourished children gained more weight than undernourished children 
(Hall et al., 2007), which is not what is hoped for in school feeding 
programmes. 
 The need for adequate remedial treatment is important when the 
outcome being measured is the haemoglobin concentration.  A study in 
Tanzania of giving iron supplements to anaemic children after treating their 
infections with hookworm and Schistosoma haematobium showed no 
improvement in the mean haemoglobin concentration, but the serum ferritin 
concentration increased, an indicator of improved iron status (Beasley et al., 
2000).  This suggests that iron was not the micronutrient limiting the 
haemoglobin concentration.   
 This does not mean that improvements in growth and nutritional status 
cannot be achieved by deworming alone, especially if there are improvements 
in appetite and food is available to children.  But to have the maximum effect 
on growth and nutritional status, therapeutic nutrients are needed as well.  A 
failure to have an impact could be because of this lack, or because the worms 
were not an important cause of any nutritional deficit in the first place. 
 But the costs of only giving supplementary food can be quite high: the 
World Food Programme estimate that it costs $34 a year to feed a child in 
school (World_Food_Programme, 2006).  An alternative is to provide 
micronutrient supplements, a deficiency of which may also act to impair 
growth, and which have been shown to reduce the intensity of reinfection with 
schistosomes (Olsen et al., 2003).  A multiple micronutrient supplement is a  
much less expensive intervention than food, and may cost only around one 
US cent/child/day if purchased in large quantities.  But the key point is that if 
any nutrient is not provided in sufficient amounts to meet demands, and 
becomes rate limiting, then growth after deworming may be constrained.   
 The weighted average gains in parameters of growth shown in Table 
12 therefore do not indicate what extra growth might be achieved after 
treatment or indicate the potential for growth, they only estimate what can be 
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achieved after giving treatment.  If a study included in the analysis showed no 
statistically significant difference between the treatment and control groups, 
the question is: did this happen because there was no effect, or because 
treated children were lacking sufficient energy or nutrients to show extra 
growth and weight gain?  A lack of effect in such studies will serve to reduce 
the weighted average, and so underestimate the potential impact of treatment.  
It is also entirely possible that anthelmintic treatment may have had no effect 
even if children had been adequately nourished.  But, as there are plausible 
biological mechanisms by which moderate to heavy burdens of worms can 
affect nutritional status, a beneficial impact on some (but not all) children 
seems likely.   
 This touches upon the aggregated distribution of worms and the 
uneven distribution of the impact of treatment.  If disease and malnutrition are 
a consequence of moderate to heavy infections, then in any given sample of 
children a minority will benefit most from treatment, so the effect of treatment 
will not be evenly distributed between children.  For example if 25 - 49 
A.lumbricoides is arbitrarily considered to be a moderate infection in children 
and 50 or more worms is a heavy infection, then of the 1,069 children aged 1 
– 14 years studied in an urban slum in Bangladesh, 18% were moderately 
heavily infected and 7% heavily infected (data from (Hall et al., 1999).  If only 
these children benefited from treatment then the impact on this 25% would in 
effect be diluted in the lack of change in the remaining 75%.  The average 
treatment effect therefore includes a large proportion of children who would 
not be expected to benefit, and would under-estimate the potential impact on 
moderately to heavily infected children.  The proportion of lightly infected 
children will be very large when the prevalence is low, and when it is less than 
50% it might be expected that very few children would benefit substantially 
from treatment.  The general consequence is that the study average will not 
capture the larger benefit experienced by any moderately to heavily infected 
children. 
 One way to control for this would be to analyse the relationship 
between any outcome and an estimate of the intensity of infection, such as 
the concentration of eggs in faeces.  This method was used by (Stephenson 
et al., 1993a) in their studies of the effect of anthelmintic treatment on 
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appetite.  This can only be done if a prior individual diagnosis is made and, if it 
is, it could be considered to be unethical to leave children untreated whose 
infections have been diagnosed.  One way to deal with this dilemma is to 
randomly allocate subjects to treatment and control groups but only diagnose 
infections in the subjects who will be treated.  This was done in a study in 
Tanzania in which in which infections were diagnosed in the control group at 
the end of the study (Bhargava et al., 2003).  The problem with doing this is 
that the intensity of infections can change in the control group as worms are 
lost or gained during a long study, so the treatment and control groups cannot 
be compared at any point during the study. 
 Two assumptions are commonly made about the effect of the intensity 
of infection,  First, that treatment has an impact only above a threshold worm 
burden, which seems reasonable, though the threshold number is likely to be 
dependent on factors such as the size and current health of the host.  
Second, that above the threshold the impact of treatment on more heavily 
infected individuals is linear.  This may not be the case, but is very difficult to 
assess without having heavily infected children as controls during a study, 
something that would be unethical.  An alternative is to examine the nature of 
the relationship between the intensity of infection with a worm and an outcome 
that is easily measurable, such as hookworm and haemoglobin concentration.  
Cross-sectional studies typically find a non-linear relationship so that the 
subjects with the heaviest infections have a markedly lower haemoglobin 
concentration than lightly infected individuals (Lwambo et al., 1992, Pritchard 
et al., 1991, Srinivasan et al., 1987, Roche and Layrisse, 1966).   
 This meta-analysis found no statistically significant effect of treating 
intestinal nematode worms on the mean haemoglobin concentration of 
children (Tables 8 and 9).  Yet the potential impact of treating worms that 
cause internal bleeding, dysentery and the loss of iron, is large.   In Africa in 
particular, many children are infected with species of Schistosoma in addition 
to hookworms, which makes it difficult to assess the impact of treating the 
intestinal nematodes alone.  An important study in Tanzania showed that 
supplements of vitamin A and iron are needed if rapid improvements in 
haemoglobin concentration are to be achieved after deworming (Mwanri et al., 
2000).  All children in the study were given albendazole and praziquantel, 
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then were divided into four groups to receive on 3 school days a week either 
iron and vitamin A placebo, vitamin A and an iron placebo, iron plus vitamin A, 
or iron and vitamin A placebos (Mwanri et al., 2000). The haemoglobin 
concentration of children given both placebos rose by an average of only 3.6 
g/L in the 12 weeks after treatment which might have been a statistically 
significant increase, but there was no untreated control group to allow this to 
be assessed.  The effects of the supplements of iron and vitamin A were 
partially additive and achieved an increase in haemoglobin concentration of 
22 g/L over the same period compared with 13.5 g/L for vitamin A alone and 
17.5 g/L for iron alone.  This study illustrates the importance of giving 
micronutrient supplements after treatment in order to achieve a rapid increase 
in haemoglobin concentration and may explain why no statistically significant 
effect of anthelmintic treatment alone was detected in the meta-analysis.  If 
the change of 3.6 g/L over 12 weeks in the control group reflects the effect of 
anthelmintic treatment alone, then it might have taken six times as long to 
achieve an increase of 22 g/L, or nearly a year and a half.  The inclusion of 
vitamin A in addition to iron makes the important point that not all anaemia is 
iron deficiency anaemia, and this could explain the results of a study in 
Tanzania that gave iron alone and failed to achieve an statistically significant 
increase in haemoglobin concentration (Beasley et al., 2000).   
 
6.3 The Cochrane Collaboration Review  
The Cochrane Collaboration supported a meta-analysis in 2000 (Dickson et 
al., 2000a, Dickson et al., 2000b).  The reviewers noted heterogeneity 
between the results of the trials they included, and considered that they could 
be due to a number of factors.  These were: the prevalence and intensity of 
infection, so that only heavily infected children benefited from treatment; the 
site of the study (school, community or health facility); the age of children; the 
prior nutritional status of children; and the manufacturer of the drug.  The 
reviewers concluded that “there is some limited evidence that routine 
treatment of children in areas where helminths are common has effects on 
weight gain, but this is not consistent between trials”.  The heterogeneity 
noted by the Cochrane Review really means a lack of effect in some trials 
which could be due, as explained here, to the fact that anthelmintic treatment 
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alone is not sufficient to achieve improved nutritional outcomes.  The review 
received considerable criticism concerning the methods of analysis and 
conclusions (Bhargava, 2000, Michael, 2000, Cooper, 2000, Savioli et al., 
2000, Bundy and Peto, 2000).   
 This review was withdrawn in 2007 and replaced by a new analysis that 
examined effects on growth and school performance (Taylor-Robinson et al., 
2007).  The review drew similar conclusions: deworming may lead to 
improved weight gain in some circumstances but not others, and no effect on 
cognition or school performance has been demonstrated (Taylor-Robinson et 
al., 2007).   
 
6.4 Characteristics of an ideal study 
Any studies that attempt to estimate the effect of anthelmintic treatment plus 
any supplement should ideally have a factorial design.  This is illustrated in 
Figure 25 in which four groups of subjects are given either deworming or not 
with a nutritional intervention or not, though it could be applied to any 
treatment.  The factorial design is powerful, but requires randomisation of 
subjects to study groups and an untreated control group to allow the effect of 
secular change to be estimated and subtracted from the effect of treatment.   
Insert Figure 25 here 
 However it is important to appreciate that it may be possible to bring 
about an improvement in a nutritional variable by a nutritional intervention 
alone, so that the effect of deworming will be masked.  An analogy of a 
leaking bucket of water may be helpful to explain this concept.  The level of 
water in a bucket, which is the measured outcome, can be sustained or even 
raised if the water flowing into the bucket is greater than the loss through any 
leaks.  Simply plugging the leaks will not raise the water level, it is necessary 
to add more water to achieve this.  But adding water alone could overcome or 
mask the effect of the leaks and lead to a rise in the water level.  Once the 
bucket is full, the excess simply overflows but the leaks continue.  This 
creates a paradox: once you start to fill the bucket the change in the level of 
water no longer accurately reflects the leakage that is occurring. 
 This analogy may apply better to anaemia than to body weight, as the 
concentration of haemoglobin does not rise unchecked, although some 
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excess nutrients such as iron and vitamin A can be stored.   When worms 
cause a loss of blood and iron and the haemoglobin concentration falls, it will 
do so when all stores of iron needed to make haemoglobin have been used 
up (Crompton and Whitehead, 1993).  Treating hookworms will not lead to an 
increase in the haemoglobin concentration if the diet does not contain enough 
nutrients to supply normal turnover, which is estimated to be about 0.8% of all 
red blood corpuscles daily, and to provide for increased erythropoiesis to 
replace corpuscles lost due to worms.  But the cumulative loss of iron and 
other nutrients could be rectified by giving supplementary food alone, provided 
that all other requirements are met.  The rate of recovery from anaemia is 
likely to be very slow without nutrient supplements, and studies of 
haemoglobin concentration after anthelmintic treatment may need to last for a 
year or more to show the full effect of treatment alone.  The same could be 
said for measuring the effect of anthelmintic treatment on growth.   
 It would be helpful for any future meta-analysis of the effects of 
anthelmintic treatments if any new research studies of the impact of treatment 
on outcomes such as growth or haemoglobin concentration had certain key 
features. 
1. The study should be done where worms and undernourished children 
are common.  A prevalence of infections with intestinal nematode 
worms of more than 70% is suggested, and where > 20% of children 
are underweight or > 40% are anaemic. 
2. A randomised, controlled design should be used.  If individuals are 
randomised to treatment and control groups then a placebo should be 
used; if clusters are randomised, then a placebo is ideal, but not 
essential.  To overcome the problem of not giving a treatment to 
subjects in a cluster trial without a placebo, both groups could be given 
some other treatment, such as vitamin A. 
3. A sample size calculation should be done.  As a rule of thumb there 
should be a minimum of 250 subjects in each group in a randomised 
trial.  In a cluster trial there should be more than 25 clusters per group 
and a design effect of 2 should be applied. 
4. Anthelmintic treatment should be given at least every 6 months.  Ideally 
initial egg counts should be reduced by >70% by the first treatment.  
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This could mean giving repeated treatment initially to achieve a high 
efficacy, unless an effectiveness trial is being done.     
5. If more than one anthelmintic is given, such as praziquantel with 
albendazole, or albendazole with micronutrient supplements, a 2 x 2 
factorial design should be considered. 
6. The key outcomes to be measured are weight and height. It may be 
helpful to measure triceps skinfold thickness and mid upper arm 
circumference to distinguish between increased adiposity and growth in 
tissues.  If infections with hookworms or T.trichiura are common, then 
the haemoglobin concentration should be measured as well with, 
ideally, a measure of irons status such as ferritin or transferrin receptor 
(WHO/CDC, 2005). 
7. If growth is to be measured, the study should last a minimum of one 
year, and two years if possible.  Specific criteria that state when a study 
should be stopped may need to be set. 
8. If the haemoglobin concentration is to be measured the study should 
last a minimum of 12 weeks, and should be continued to 52 weeks if 
possible if no micronutrient supplements are given after treatment. 
9. Drug efficacy should be assessed 21 days after each round of 
treatment as a matter of good practice, to assess the development of 
any anthelmintic resistance. 
10. The gains in any parameter related to growth should be standardised 
as mean gain per year.  The mean and standard deviation of all 
outcome measures and any derived indices should be given in any 
report or paper for each group, with the sample sizes.  If subjects are 
studied in clusters, then this should be taken into account during the 
analysis. 
 
6.5 Implications for programmes 
Deworming is an easy and inexpensive thing to do, and the drugs are very 
safe.  Treatment can be popular with parents (Brooker et al., 2001).  Most 
anthelmintics can be given as a single dose so no adjustment for body weight 
is necessary, and a single 400 mg tablet of albendazole or 500 mg of 
mebendazole can be given to all children older than 1 year (WHO, 2002b),  
 61
though a syrup should be given to very young children.  The United Nations 
Children’s Fund in Ethiopia have issued warnings that young children should 
not be forced to take tablets because of the risk of choking.  Anthelmintic 
drugs should not be given in the first trimester of pregnancy (WHO, 1994b).  
Anthelmintic drugs are usually available over the counter and do not require a 
prescription, except in developed countries. 
 Over the last few years the costs of albendazole and mebendazole 
have been reduced to less than 5 US cents a tablet when bought in large 
quantities and, according to the WHO, these drugs can be given safely to all 
children once a year in areas where the prevalence of infection is more then 
20% and twice a year where the prevalence is more than 50% (WHO, 2006).  
The new recommendations are shown in Table 14.  To promote mass 
deworming the World Health Assembly in 2001 passed resolution WHA54.19 
asking countries to administer anthelmintic treatments annually to at least 
75% of all school-age children at risk of morbidity by 2010 (WHO, 2002a). 
Insert Table 14 here 
 There are three justifications for giving mass treatment at least once a 
year in areas where the prevalence of infection with all species of intestinal 
nematode worms is greater than 50%.   
 First, because the probability of disease increases exponentially above 
a prevalence of 50% (see Figure 3).   
 Second, the cost of diagnosis is typically many times the cost of 
treatment.  When the prevalence is greater than 50% diagnosis becomes a 
matter of identifying uninfected people who do not need treatment, and so the 
cost per case of finding them increases with the prevalence.   
 Third, most anthelmintic drugs, and the benzimidazoles in particular, 
are very safe, and there is no known harm in treating people who are not 
infected.  Benzimidazoles have been taken daily for long periods to treat 
hydatid disease (El-On, 2003, Horton, 2003a) and when used to treat 
intestinal nematodes the overall frequency of side effects is about 1% (Horton, 
2000).  Although one of the potential studies identified for the meta-analysis 
reported evidence of an adverse effect on the growth of children given 400 mg 
albendazole given for 3 days, there was no untreated control group (so the 
study was excluded from the present analysis) and the children treated with 
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albendazole were compared with children treated with another anthelmintic, 
pyrantel embonate (Forrester et al., 1998). 
 The use of a 20% threshold at which to apply annual mass treatment in 
school-age children has cost-benefit implications.  When the prevalence of 
infection is less than 50% the majority of children are uninfected and perhaps 
only a few percent of children will actually benefit from treatment.  Although 
the cost per child treated may be small in terms of the cost of each tablet, as 
the prevalence drops the costs per infected child treated will increase.  This is 
shown in Figure 26 for a drug costing 3 US cents per treatment.  When the 
prevalence is 50% the cost per infected child treated is twice the cost per child 
treated, or 6 US cents per child; when the prevalence is only 20% the cost per 
infected child treated is five time the cost per child treated or 15 US cents per 
child; and if only 5% of all children actually benefit from treatment the cost per 
beneficiary is 20 times the cost of the treatment or 60 US cents per child.  
 Although these unit costs may seem small in absolute terms, the total 
cost to a government may be large.  For example if the Ethiopian government 
was considering treating the 11.5 million children enrolled in primary schools 
in 2005 with a drug costing 3 US cents per treatment, and if the prevalence of 
infection according to a recent national survey is 30% (SC/US, 2007), then of 
the $345,000 it will cost to buy drugs, 70% or $241,500 will be spent on 
treating uninfected children.   
 These costs do not take into account the additional financial or 
opportunity costs of delivering and administering tablets.   
Insert Figure 26 here 
 The main issue for deworming programmes is how to deliver 
treatments at low cost to the three main groups who would benefit most from 
treatment: pre-school children, school-age children, and women of 
reproductive age.  
 As there are many current programmes delivering treatments such as 
vaccinations and vitamin A to children less than 5 years, the additional cost of 
giving a tablet of albendazole or mebendazole is minimal.  In recognition of 
this, the WHO and UNICEF now recommend deworming children as a part of 
all routine health programmes, such as when vitamin A is given 
(WHO/UNICEF, 2004), and anthelmintic treatment is also recommend as a 
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part of the Integrated Management of Childhood Illnesses after any acute 
illness has ceased.   
 A commonly unrecognised concern arises because of the lack of over-
lap between health programmes for pre-school children, which typically stop 
at 5 years of age, and programmes for school children, which begin when 
children enrol in school.  As the official age of enrolment in basic education in 
many countries is 6 or even 7 years of age, even if all children actually enrol in 
school at the correct age, there is a gap of 1 – 2 years when they may fall 
between programmes and miss out on treatment.  As late-enrolment in school 
is very common in sub-Saharan Africa (Partnership for Child Development, 
1998b)  and late enrolment is strongly associated with stunted growth and 
anaemia (Partnership for Child Development, 1999b, Hall et al., 2001) the gap 
between programmes may be as much as four or five years, and such 
children may be in greater need of treatment than those who are actually in 
school. 
 In countries where enrolment rates are high, school health programmes 
offer an effective mechanism to reach a large proportion of school-age 
children (Hall et al., 1996), an age group that harbours a large proportion of all 
worms in a community.  The cost of delivering anthelmintics to schoolchildren 
has been shown to be a few US cents per child (Partnership for Child 
Development, 1999a, Partnership for Child Development, 1998a).  In addition 
to the potential nutritional benefits of treatment, periodically giving 
anthelmintics to school children alone has other benefits, as it can serve to 
bring down transmission to other, untreated groups (Butterworth et al., 1991, 
Bundy et al., 1992b, Asaolu et al., 1991).  Such externalities as they are called 
by economists, are not captured in a meta-analysis such as this, which 
examines only one outcome at a time.   
 It is also possible that, as well as affecting growth and micronutrient 
status, intestinal nematodes may affect children’s cognitive function and 
educability, although the evidence for this is mixed and often comes from 
cross-sectional associations, which are easily confounded (Dickson et al., 
2000b, Nokes et al., 1992a, Nokes et al., 1992b, Watkins and Pollitt, 1997, 
Jukes et al., 2002, Sakti et al., 1999).  The Cochrane Review of 2007 
concluded that there was insufficient evidence that treating worms improves 
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cognitive performance, which included educational outcomes including 
attendance and tests of educational achievements (Taylor-Robinson et al., 
2007).  The controlled trial of six-monthly deworming for two years in Viet 
Nam found no statistically significant difference between treatment and 
controls in terms of tests of mathematics and Vietnamese (Partnership for 
Child Development, 2001).  
 The last group that would benefit considerably from periodic 
anthelmintic treatment are women of reproductive age, although treatment 
should only be given before pregnancy or after the first trimester.   
Nevertheless accidental treatment does not seem to be dangerous: a study of 
some 400 Sri Lankan women who had taken mebendazole during their first 
trimester of pregnancy did not find a greater rate of congenital defects than in 
pregnant women who had not taken the drug (de Silva et al., 1999).  But the 
sample size was too small to detect a greater risk of rare congenital defects, 
so the recommendation of the study was still to avoid treatment with 
anthelmintics (de Silva et al., 1999).  
 The main effect of anthelmintic treatment on pregnant women is likely 
to be on haemoglobin concentration as a result of treating infections with 
hookworm or Schistosoma spp.   A randomised controlled trial in Sierra Leone 
of giving albendazole to pregnant women after their first trimester prevented a 
fall in haemoglobin concentration of 6.6 g/L (Torlesse and Hodges, 2001, 
Torlesse and Hodges, 2000).  When albendazole was given with iron, both 
treatments prevented a fall in haemoglobin concentration of 13.7 g/L (Torlesse 
and Hodges, 2001, Torlesse and Hodges, 2000).    
 As a general rule for all programmes in which anthelmintic treatment for 
worms is given, drugs should not be administered to individuals who are sick 
for any reason.  This is not because the drug may be ineffective, though it 
may be if there is diarrhoea.  The reason for not giving treatment is because 
of the possibility that the subject may die of a pre-existing illness, and it could 
be concluded that the anthelmintic had caused the death.  In any programme 
in which very large numbers of children are being treated on the same day, 
such an event becomes increasingly statistically probable, so every effort 
should be made to ensure that only otherwise healthy children are treated.  A 
possible example of this was the >30 deaths reported after the administration 
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of vitamin A to some 3 million young children in the state of Assam in India in 
2001 (West and Sommer, 2002), although there was some concern that 
children may have been overdosed (Kapil, 2004, Kapil, 2002).  Reports of 
deaths of schoolchildren during mass deworming have not been documented. 
 The other concern during mass treatment campaigns is for adolescent 
girls who may be pregnant and either not know it, or be afraid to report it. 
Teratogenic effects of drugs are most likely to occur during the first few weeks 
of pregnancy, a period when a woman may not yet be aware that she is 
pregnant.   It cannot be assumed that school-age girls are not sexually active.  
A study of 9,000 schoolchildren in grades 4 to 6 in Tanzania found that 20% 
of girls reported having had sex, but only 39% of 114 girls with biological 
markers of sexual activity such as an infection, acknowledged having had sex, 
indicating that such activity was greatly under-reported (Todd et al., 2004).  In 
an analysis of official education statistics, also in Tanzania, pregnancy was 
reported to be a cause of school drop out for 6 or 7 girls per 1,000 in grades 6 
and 7 respectively (Partnership for Child Development, 1998b).   
 These data should provide a warning to programmes that give mass 
treatment with anthelmintic drugs to school-age children as well for those 
considering adding mega-dose supplements of vitamin A to treat vitamin A 
deficient or anaemic adolescent girls.  It cannot be assumed that adolescent 
girls are not pregnant. 
 
6.6 Conclusions  
Treating intestinal nematode worms can lead to significantly better weight gain 
and growth when treated children are compared with untreated controls.   
 The magnitude of the effect of treatment is specific to local 
epidemiological circumstances, and not all infected children will benefit to the 
same degree, if at all.   
 If no significant effect of anthelmintic treatment is detected in a study, it 
cannot be assumed that worms did not contribute to undernutrition; it is likely 
that removing worms is insufficient to lead to improved growth without extra 
food and nutrients. 
 The maximum size of any effect of treating worms cannot be estimated; 
studies can only indicate what difference is achievable.  To show a significant 
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effect it is necessary to have an untreated control group and a sufficient 
period of follow up.  This is likely to become less tenable given the measured 
benefits of treating worms that have been shown.  Nevertheless it would be 
useful to have more studies of the effectiveness of anthelmintics delivered 
through health programmes, especially those that focus on pre-school and 
school-age children, and perhaps given with multiple micronutrients to make 
sure that no vitamin or mineral is a factor limiting catch-up growth. 
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Table 1.  The names of the most common intestinal helminth infections of humans, their infectious stages, the obligatory 
intermediate host, and the stage that is infectious to humans. 
 
 
Latin name 
  
English name 
 Class or 
Phylum 
Infectious stage 
in faeces 
 Intermediate 
host 
 Stage infectious to  
humans 
          
Fasciolopsis buski 
 Intestinal fluke  Trematoda Egg  Water snail  Metacercaria on vegetation 
Echinostoma spp 
 Intestinal fluke  Trematoda Egg  Water snail  Metacercaria in snails 
 
         
Taeniaa saginata 
 Beef tapeworm  Cestoidea Egg in proglottid  Cow and bovids  Cysticercus in beef 
Taeniaa solium 
 Pork tapeworm  Cestoidea Egg in proglottid  Pig and swine  Cysticercus in pork 
Hymenolepis nana 
 Dwarf tapeworm  Cestoidea Egg in proglottid  Beetle, flea  Cysticercoid  in insect 
Hymenolepis diminuta 
 Rat tapeworm  Cestoidea Egg in proglottid  Insect  Cysticercoid  in insect 
Diphyllobothrium latum 
 Fish tapeworm  Cestoidea Egg  Fish  Plerocercoid in raw fish 
 
         
Enterobius vermucularis 
 Pinworm  Nematoda Egg  No  Larva in egg shell 
Strongyloides stercoralis 
 Threadworm  Nematoda Egg or larva  No  Free-living larva 
Ascaris lumbricoides 
 Large roundworm  Nematoda Egg   No  Larva in egg shell 
Trichuris trichiura  
 Whipworm  Nematoda Egg   No  Larva in egg shell 
Ancylostoma duodenale  
 Hookworm  Nematoda Egg   No  Free-living larva 
Necator americanus  
 Hookworm  Nematoda Egg  No  Free-living larva 
          
a
  Also known as genus Taeniarhynchus
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Table 2.  Estimated fecundity of fertilised females of the major species of 
intestinal nematode worms.  Data from (Sinniah, 1982, Anderson and May, 
1991, Bundy and Cooper, 1989).  The numbers are based on very few data 
and do not take into account density dependent fecundity or geographical 
variation in fecundity.  At best they can be considered as indicative of the 
relative orders of magnitude of egg production. 
 
Species  Eggs/female worm 
   
Ascaris lumbricoides  
 < 200,000 
Trichuris trichiura  
 3,000 – 20,000 
Ancylostoma duodenale  
 10,000 – 20,000 
Necator americanus  
 3,000 – 6,000 
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Table 3.  Estimates of the population and number of people infected in 
millions, and the prevalence of infection with the main types of intestinal 
nematodes by region and age group.  Data extracted from (de Silva et al., 
2003). 
 
 Age range (years)  % 
Ascaris lumbricoides 
Popul-
ation 0-4 5-9 10-14 ≥ 15 Total infected 
        Latin American & Caribbean 530 8 10 10 56 84 15.8 
Sub-saharan Africa 683 28 28 25 92 173 25.3 
Middle east & north Africa 313 3 3 3 14 23 7.3 
South Asia 363 13 15 13 56 97 26.7 
India 1027 15 18 17 89 139 13.5 
East Asia & the Pacific 564 20 25 25 134 204 36.2 
China 1295 35 44 51 371 501 38.7 
        
Total 4775 122 143 144 812 1221 25.6 
        
 Age range (years)  % 
Trichuris trichiura 
Popul-
ation 0-4 5-9 10-14 ≥ 15 Total infected 
        Latin American & Caribbean 530 10 12 12 66 100 18.9 
Sub-saharan Africa 683 26 27 23 86 162 23.7 
Middle east & north Africa 313 1 1 1 4 7 2.2 
South Asia 363 10 11 10 43 74 20.4 
India 1027 8 9 9 47 73 7.1 
East Asia & the Pacific 564 16 19 19 105 159 28.2 
China 1295 15 19 22 163 219 16.9 
        
Total 4775 86 98 96 812 1092 22.9 
        
 Age range (years)  % 
Hookworm 
Popul-
ation 0-4 5-9 10-14 ≥ 15 Total infected 
        Latin American & Caribbean 530 1 3 5 41 50 9.4 
Sub-saharan Africa 683 9 18 29 142 198 29.0 
Middle east & north Africa 313 0 1 1 8 10 3.2 
South Asia 363 2 5 8 44 59 16.3 
India 1027 2 5 8 56 71 6.9 
East Asia & the Pacific 564 4 9 16 120 149 26.4 
China 1295 3 9 18 173 203 15.7 
        
Total 4775 21 50 85 584 740 15.5 
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Table 4.  The estimated number and percentage of children aged 5 – 9 years infected with the three main species of soil-
transmitted helminths and the population at risk in 2002 derived from (de Silva et al., 2003) and (Hall and de Silva, 2007) in the 
main geographic areas covered by the WHO.  Data for some countries are missing.  The estimate for the number and percentage 
infected with any of these three species has assumed that where they are endemic, they occur in the same populations and that 
the chances of being concurrently infected with two or more species are independent.  
 
 
  Population  Ascaris lumbricoides   Trichuris trichiura  Hookworms  Any species 
World Bank regions  No x 106  No x 106  %  No x 106  %  No x 106  %  No x 106  % 
          Asia & W. Pacific 124.2 56.3 45.3 27.6 22.3 12.3 9.9 76.6 61.7 
South-east Asia B 28.4 9.6 33.6 9.6 33.9 5.3 18.6 18.3 64.3 
South-east Asia D 147.3 33.0 22.4 21.2 14.4 9.1 6.2 55.5 37.7 
Americas B 45.0 7.0 15.5 8.8 19.5 2.2 4.8 15.8 35.2 
Americas D 9.1 3.4 37.7 3.2 35.0 0.9 9.5 5.8 63.3 
Middle east B 15.3 1.0 6.7 0.0 0.3 0.0 0.2 1.1 7.1 
Middle east D 47.2 5.0 10.6 1.4 3.0 1.2 2.6 7.3 15.5 
Africa D 44.6 13.3 29.7 10.0 22.3 7.6 17.0 24.4 54.7 
Africa E 51.9 14.8 28.6 16.9 32.5 10.1 19.4 31.7 61.1 
          
Total 513.0 143.4 27.9 98.7 19.2 48.6 9.5 242.8 47.3 
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Table 5.  The threshold concentrations of worm eggs in faeces used to 
classify infections as light, moderate and heavy proposed by a WHO Expert 
Committee in 2002 (WHO, 2002a).  No references or data are given in 
support of these numbers. 
 
Intensity  Ascaris lumbricoides  Trichuris trichiura  Hookworms 
       Low  1- 4,999  1 – 999  1 – 1,999 
Moderate  5,000 – 49,999  1,000 – 9,999  2,000 – 3,999 
High  ≥ 50,000  ≥ 10,000  ≥ 4,000 
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Table 6.  Estimates of the life span of the major species of intestinal 
nematode worms of humans (data from (Anderson and May, 1991)). 
 
Species  Life span (years) 
   Ascaris lumbricoides 
 1 – 2 y 
Trichuris trichiura  
 1 – 2 y 
Ancylostoma duodenale  
 2 – 3 y 
Necator americanus  
 2 – 3 y 
Enterobius vermicularis 
 < 1 y 
Strongyloides stercoralis  
 > 50 ya 
   a
 Resulting from auto-infection 
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Table 7.  The typical range in cure rates of drugs to treat intestinal nematode 
infections.  The doses are those recommended by the World Health 
Organization (WHO, 1995).  The data for the drugs that paralyse worms have 
been derived from (Albonico et al., 2003, Gustafsson et al., 1987, Huq et al., 
1982). The data for the metabolic inhibitors is summarised from (Bennett, 
2000), and represents the approximate inter-quartile range in an analysis of 
multiple studies of drug efficacy.  The data have been combined for the 
metabolic inhibitors albendazole and mebendazole, except for hookworm, for 
which there is a difference between species in efficacy. 
 
  Drugs that paralyse  Metabolic inhibitors 
  
Levamisole, 40 mg 
 
Albendazole, 400 mg 
  
Piperazine, 75 mg/kg 
 
Mebendazole, 500 mg 
  
Pyrantel pamoate, 10mg/kg 
 
Tiabendazole, 25 mg/kg, 3d 
Species  Cure rate  ERRa  Cure rate  ERR 
         
Ascaris lumbricoides  
 80 - 100 %  95 – 100%  95 – 99 %  99 – 100% 
         
Ancylostoma duodenale 
Necator americanus   
 80 – 100% 
60 – 90% 
 50 – 70% 
 
 70 – 90%b 
20 – 80%c 
 75 – 95%b 
55 – 95%c 
         
Trichuris trichiura  
 Poord  20 – 60%  10 – 70%  50 – 90% 
         
 
aERR = egg reduction rate; b Albendazole 400 mg; c Mebendazole 500 mg; dUnless pyrantel 
given with oxantel 
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Table 8.   Data from  a study in Zanzibar of the efficacy of treating intestinal 
nematode infections with either albendazole or mebendazole (Albonico et al., 
1994).  Even though the drugs have a very similar mode of action there were 
statistically significant differences in the cure rates and egg reduction rates, 
particularly for hookworms. 
 
Species  Drug  n  Cure rate  Egg reduction rate 
 
        Ascaris lumbricoides  
 Albendazole  1,174  98.9  99.6 
  Mebendazole  1,120  97.8  99.3 
         
Hookworms  Albendazole  1,174  56.8***  97.7*** 
  Mebendazole  1,120  22.4  82.4 
         
Trichuris trichiura  
 Albendazole  1,174  10.5**  73.3*** 
  Mebendazole  1,120  14.2  81.6 
         
 
** = P < 0.01; *** = P < 0.001 
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Table 9.  The terms used to search Medline for papers.  MeSH denotes a 
specific Medical Subject Heading used as a search term. 
 
Worms Treatments Outcomes 
 
"intestinal worms" 
"intestinal parasites" 
geohelminth* 
helminth* 
 
Ascaris 
roundworm  
Trichuris 
whipworm 
Necator 
ancylostoma 
hookworm 
 
"Ascaris lumbricoides” 
[MeSH]   
Trichuris [MeSH] 
“Necator americanus” 
[MeSH]  
“Ancylostoma 
duodenale” [MeSH] 
 
 
deworm* 
de-worm*  
anthelmintic* 
antihelmintic* 
vermifuge 
 
benzimidazole  
albendazole 
mebendazole 
pyrantel 
levamisole 
piperazine 
 
"Ascariasis/drug therapy" [MeSH] 
"Ascariasis/prevention and 
control" [MeSH] 
"Ascariasis/therapy" [MeSH] 
 
"Hookworm infections/drug 
therapy" [MeSH]  
"Hookworm infections/prevention 
and control" [MeSH] 
"Hookworm infections/therapy" 
[MeSH] 
 
"Trichuriasis/drug therapy" 
[MeSH] 
"Trichuriasis/prevention and 
control" [MeSH] 
"Trichuriasis/therapy"[MeSH] 
 
 
weight 
height 
length 
growth  
skinfold  
"arm 
circumference" 
"nutritional 
status" 
malnutrition  
anthropometr* 
 
haemoglobin 
hemoglobin 
"iron status" 
anaemia 
anemia 
 
retinol 
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Table 10.  A summary of main characteristics of the studies included in the meta-analysis.   
 
Authors  Ascaris Trichuris Hookworm Anya 
Age 
range N Drugb Dose Frequency Treatment Control 
             
Adams et al. (1994).  
 29% 84% 93% NR  5-10 y 56 ABZ 400 mg/d x 3 d Once None Placebo 
Alderman et al. (2006)   
 ~ 18% ~ 7% ~44% ~ 56% 1-7 y 27,995 ABZ 400 mg 2 - 5 times every 6 mo None Untreated 
Dossa et al. (2001).  
 38% 47% 13% NR 3-5 y 177 ABZ 200 mg/d x 3 d Twice, 1 month apart Iron Placebo 
Gupta et al. (1982).  
 51-72% 9% 0% NR 24-61 mo 159 PPZ 75 mg/kg/d x 2d Once None Placebo 
Koroma et al. (1996). Rural 
 46% 25% 1% NR 6-10 y 98 ABZ 400 mg Once None Placebo 
Koroma et al. (1996). Urban 
 32% 10% 65% NR 6-10 y 99 ABZ 400 mg Once None Placebo 
Northrop-Clewes et al. (2001).  
 78% 65% 4% NR 2-5 y 117 PP 10 mg/kg Single dose then None Placebo 
        MBZ 500 mg bi monthly for 1 year   
PCD (2002, unpublished).   71% 84% 7% 93% 7-8 y 2,659 ABZ 400 mg Every 6 mo, 5 times None Untreated 
Sarker et al. (2002).   
 78% NR NR NR 2-12 y 85 PP 11 mg/kg Once None Placebo 
Simeon et al. (1995).   
 42-50% 100% NR NR 6-12 y 407 ABZ 400 mg/d x 2 d Once None Placebo 
Stephenson et al. (1989c).  
 49% 97% 87% NR 6-16 y 150 ABZ 400 mg Once None Placebo 
Stephenson et al. (1993a).   
 26-35% 81-92% 85-88% NR 6-15 y 284 ABZ 600 mg Once or twice 3.6 m later None Placebo 
Stephenson et al. (1993b).   
 41% 98% 96% NR 7-13 y 53 ABZ 600 mg Once Food Placebo 
Stoltzfus et al. (1997).   
 66-76% 95-97% 91-96% NR Not stated 3063 MBZ 500 mg 2x or 3 x per year None Unclear 
Stoltzfus et al. (1998).   
 67-76% 95-97% 91-96% NR Not stated 2924 MBZ 500 mg 2x or 3 x per year Iron Untreated 
Stoltzfus et al. (2004).   
 42-44% 71-72% 54% NR 6-71 mo 459 MBZ 500 mg Once every 3 mo for 1 y Iron Placebo 
Tanumihardjo et al. (1996)   
 100% 17-27% NR NR 0.6-6.6 y 309 ABZ 400 mg Once Retinol Placebo 
Tanumihardjo et al. (2004).  
 100% 28% NR NR Not stated 51 ABZ 400 mg Once Retinol Untreated 
Thein-Hlaing et al. (1991).   
 81- 83% 5-7% 1-2% NR 2-12 y 1206 LEV Not stated Once None Untreated 
Watkins et al. (1996).   
 91-92% 78-85% NR NR < 12 y 228 ABZ 400 mg Once None Placebo 
             
a NR = Not reported;  b ABZ = Albendazole; LEV = Levamisole; MBZ = Mebendazole; PP = Pyrantel pamoate; PPZ = Piperazine
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Table 11.  The countries from which data were published in papers on the 
effect of anthelmintic treatment on the growth and nutritional status of 
children.  Also shown is the number of times each country is represented in 
papers found during the literature search and the papers eventually used in 
the meta-analysis.  One paper reported data from China, the Philippines and 
Kenya (Olds et al., 1999) so the total number of papers is 58 rather than 60.   
All other papers only presented data from one country. 
 
 
Country  Papers found  Papers used 
     Benin  1  1 
Botswana  1  0 
Ethiopia  2  0 
Kenya  11  4 
Sierra Leone  1  1 
South Africa  4  0 
Tanzania  6  3 
Uganda  1  1 
Zaire  1  0 
     China  1  0 
Indonesia  7  2 
Malaysia  3  0 
Myanmar  1  1 
Philippines  1  0 
Viet Nam  1  1 
     Bangladesh  5  2 
India  3  0 
Sri Lanka  1  0 
     Brazil  2  0 
Guatemala  2  2 
Haiti  2  0 
Jamaica  2  1 
Mexico  1  0 
     Total  58  19 
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Table 12.  Summary of changes in primary and secondary outcome measures 
for studies in which any drug to treat intestinal nematode worms was given.  
The drugs were: albendazole and mebendazole, levamisole, piperazine or 
pyrantel pamoate 
 
 
Primary outcome measure 
 No. of 
studies 
 No. of 
participants 
 Estimate  
(95% C.I.) 
 
 
P 
         
Weight (kg)  11  33,860  0.21 (0.17, 0.26)  <0.001 
Height (cm)  9  5,801  0.11 (0.03, 0.19)  0.01 
MUACa (cm)  7  3,325  0.30 (0.23, 0.37)  <0.001 
Triceps skinfold (mm)  5  3,021  0.11 (0.03, 0.18)  0.04 
Haemoglobin (g/dL)  5  2,178  -0.93 (-2.97, 1.10)  0.37 
% DR/Rb ratio  2  204  0.17 (-0.60, 0.93)  0.67 
         
 
Secondary outcome measures 
 No. of 
studies 
 No. of 
participants 
 Estimate  
(95% C.I.) 
 
 
P 
         
Weight-for-age z-score  5  557  0.06 (0.03, 0.08)  <0.001 
Height-for-age z-score  6  961  0.09 (0.06, 0.11)  <0.001 
Weight-for-height z-score  4  378  0.38 (0.30, 0.46)  <0.001 
Weight-for-age % median  4  401  2.52 (1.95, 3.08)  <0.001 
Height-for-age % median  4  401  0.27 (0.12, 0.42)  <0.001 
Weight-for-height % median  3  323  2.64 (1.97, 3.30)  <0.001 
         
 
a
 MUAC = mid upper-arm circumference 
b
 DR/R = dehydroretinol/retinol 
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Table 13.  Summary of changes in primary and secondary outcome measures 
for studies in which albendazole or mebendazole were given to treat intestinal 
nematode worms.   
 
 
Outcome measure 
 No. of 
studies 
 No. of 
participants 
 Estimate  
(95% C.I.) 
 
 
P 
         
Weight (kg)  8  33,275  0.18 (0.13, 0.23)  <0.001 
Height (cm)  6  5,227  0.08 (-0.01, 0.17)  0.07 
MUACa (cm)  6  3,228  0.30 (0.23, 0.37)  <0.001 
Triceps skinfold (mm)  5  3,021  0.11 (0.03, 0.18)  0.004 
Haemoglobin (g/dL)  5  2,178  -0.93 (-2.97, 1.10)  0.37 
% DR/Rb ratio  2  204  0.17 (-0.60, 0.93)  0.67 
         
 
Secondary outcome measure 
 No. of 
studies 
 No. of 
participants 
 Estimate  
(95% C.I.) 
 
 
P 
         
Weight-for-age z-score  4  468  0.06 (0.03, 0.08)  <0.001 
Height-for-age z-score  5  855  0.09 (0.06, 0.11)  <0.001 
Weight-for-height z-score  4  378  0.38 (0.30, 0.45)  <0.001 
Weight-for-age % median  2  242  3.16 (2.51, 3.81)  <0.001 
Height-for-age % median  2  242  0.31 (0.14, 0.47)  <0.001 
Weight-for-height % median  2  242  2.73 (2.03, 3.44)  <0.001 
         
 
a
 MUAC = mid upper-arm circumference 
b
 DR/R = dehydroretinol/retinol 
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Table 14.  The prevalence of any species of intestinal nematode that warrants 
mass treatment criteria for applying treatments and the target groups. 
 
Risk 
category 
  
Prevalence 
  
Target groups and treatments 
       
High  ≥ 50%  Treat all school-
age children twice 
a year 
 Treat all: 
• pre-school children 
• women of child-
bearing age except 
in first trimester 
• adults at risk 
       
Low  ≥ 20% to < 
50% 
 Treat all school-
age children once a 
year 
 Treat all: 
• pre-school children 
• women of child-
bearing age except 
in first trimester 
• adults at risk 
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Figure 1.  The proglottid of Taenia saginata (at the end of the stick) crawling 
away from a human stool in a trail of mucus.  The sample was collected from 
a Pokot man in western Kenya, an ethnic group that traditionally enjoys eating 
undercooked beef (Hall et al., 1981).  
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Figure 2.  The prevalence of infection with A.lumbricoides in 11 age classes 
of males living in an urban slum in Dhaka, Bangladesh (data from (Hall et al., 
1999)). 
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Figure 3  The typical relationship between the prevalence and the mean 
worm burden for intestinal nematode worms (see (Guyatt et al., 1990)).  The 
shape of the curve is derived from data collected during a study of 
A.lumbricoides in Bangladesh (Hall et al., 1999). 
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Figure 4.  A diagrammatic representation of the proportions of a population of 
100% who are infected with one, two or three types of worms when the 
prevalence of infection with Ascaris lumbricoides is 60%, Trichuris trichiura is 
50% and hookworm is 40%.  It is assumed that the probability of each 
infection is independent of each other and that probability of having two or 
more infections is multiplicative. 
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Figure 5.   The average number of worms recovered from males in 11 age 
classes living in an urban slum in Bangladesh (Hall et al., 1999). 
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Figure 6.  The distribution of A.lumbricoides in 1,765 people living in an urban 
slum in Dhaka, Bangladesh (Hall et al., 1999).  The black line shows the 
negative binomial distribution.   
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Figure 7.  The cumulative percentage of worms recovered from 1,511 people 
infected with Ascaris lumbricoides in an urban slum in Bangladesh ranked 
according to worm burdens from zero to the maximum of 187 worms, plotted 
against the cumulative number of subjects from whom they were recovered 
(data from (Hall et al., 1999). 
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Figure 8  The prevalence of infection with A.lumbricoides at three rounds of 
treatment six months apart (Hall et al., 1992). 
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Figure 9.  The mean worm burden with A.lumbricoides at three rounds of 
treatment six months apart (Hall et al., 1992). 
 
0
5
10
15
20
25
0 10 20 30 40 50 60
Mean age of age class (years)
M
e
a
n
 
w
o
rm
s/
pe
rs
o
n
Round 1
Round 2
Round 3
 
 108
Figure 10.  The prevalence of infection with A.lumbricoides among 445 
school-age children in Bangladesh and the mean worm burden at baseline (0 
months) and at two treatments six months apart (data from study of (Hall et 
al., 1999).  The dotted lines represent extrapolated trend lines if treatments 
had been given twice more at six month intervals. 
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Figure 11  The average and 95% confidence intervals of body weight of two 
hypothetical groups of 300 children, on treated regularly with an anthelmintic 
and an untreated control group followed up for 3 years. 
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Figure 12.  A conceptual model of the effect of worms on an outcome 
measure, and the need for remedial therapy after anthelmintic treatment to 
bring about a recovery. 
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Figure 13.  The effects of treating intestinal worms on body weight (kg).  To 
interpret the figure, see Section 5.3. 
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Figure 14 The effects of treating intestinal worms on height (cm).  To interpret 
the figure, see Section 5.3. 
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Figure 15.  The effects of treating intestinal worms on mid upper-arm 
circumference (mm).  To interpret the figure, see Section 5.3. 
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Figure 16.  The effects of treating intestinal worms on triceps skinfold 
thickness (mm). To interpret the figure, see Section 5.3. 
 
 
 
 
 
 
 
Figure 17.  The effects of treating intestinal worms on z-score of weight-for-
age).  To interpret the figure, see Section 5.3. 
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Figure 18.  The effects of treating intestinal worms on z-score of height-for-
age.  To interpret the figure, see Section 5.3. 
 
 
 
 
 
Figure 19.  The effects of treating intestinal worms on the difference in z-
score of weight-for-height.  To interpret the figure, see Section 5.3. 
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Figure 20.  The effects of treating intestinal worms on percentage of the 
median weight-for-age.  To interpret the figure, see Section 5.3. 
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Figure 21.  The effects of treating intestinal worms on percentage of the 
median height-for-age.  To interpret the figure, see Section 5.3. 
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Figure 22.  The effects of treating intestinal worms on percentage of the 
median weight-for-height.  To interpret the figure, see Section 5.3. 
 
 
 
 
 
 
Figure 23.  The effects of treating intestinal worms on haemoglobin 
concentration (g/dL).  To interpret the figure, see Section 5.3. 
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Figure 24.  The effects of treating intestinal worms on the dehydroretinol/ 
retinol ratio expressed as a percentage.  To interpret the figure, see Section 
5.3. 
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Figure 25.  A 2 by 2 factorial design to estimate the effect of deworming with 
or without a nutritional treatment or not.  
  
  Anthelmintic treatment 
  Yes No 
Yes A B Nutritional 
intervention No C D 
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Figure 26.  The costs of anthelmintic treatment per child for a drug costing 3 
US cents per child and the costs per infected child treated. 
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